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  81. Summary 
 
The transcription factor p63 is part of the p53 protein family, which consists of 
three members, p53, p63 and p73. P63 shares structural similarity with all family 
members, but is associated to different biological functions than p53 or p73. 
While p53 is mainly linked to tumor suppression and p73 is connected with 
neuronal development, p63 has been connected to critical biological roles within 
ectodermal development and skin stem cell biology as well as supervision of the 
genetic stability of oocytes. Due to its gene structure p63 is expressed as at least 
six different isoforms, three of them containing a N-terminal transactivation 
domain. The isoforms that are of biological relevance both have a C-terminal 
inhibitory domain that negatively regulates the transcriptional activity. This 
inhibitory domain is supposed to contain two individual components of which one 
is internally binding and masking the transactivation domain while the other one 
can be sumoylated. To further investigate this domain a mutational analysis with 
the help of transactivation assays in SAOS2 cells was carried out to identify the 
critical amino acids within the inhibitory domain and the impact on transcriptional 
activity of TAp63α, the p63-isoform which is essential for the integrity of the 
female germline. The results of these experiments show that a stretch of 
approximately 13 amino acids seems to be important for the regulation of 
transcriptional activity in TAp63α, due to the increased transcriptional activity 
occurring in this region after mutation. Additional experiments showed that this 
mechanism is distinct from sumoylation, which seems to have only implications 
for the intracellular level of TAp63α. As a conclusion, the C-terminus of the 
Tap63α is essential for two different mechanisms, which control the 
transcriptional activity of the protein. Both regulatory elements are independent 
from each other and can now be restricted to certain amino acids. Activation of 
the wild type protein might take place in the identified region via post-translational 
modification. Furthermore an inhibition assay was carried out to test if the same 
region might have implications on the second biological relevant isoform ΔNp63α. 
The results show that the same amino acids which show an impact on 
transcriptional activity in Tap63α lead to a significant change in functional 
behaviour of ΔNp63α. There is a possibility that both proteins are regulated with 
  9opposite effects via the same mechanisms, based at the C-terminus of the p63α-
isoforms. In both cases a modification of these residues could lead to a more 
opened conformation of the protein with consequences on promoter binding, 
which can be even important for ΔNp63α with respect to promoter squelching. 
Both α-isoforms seem to be regulated via the C-terminus and to elucidate if that 
is also the case for TAp63γ a deletion analysis was carried out. The results show 
that there are also amino acids within the C-terminus of TAp63γ, which have 
implications on the transcriptional activity of the protein. Therefore the C-terminus 
seems to play a major role for regulation of diverse p63 isoforms. 
 
 
  102. Zusammenfassung 
 
Der Transkriptionsfaktor p63 ist Mitglied der p53-Familie, zu welcher auch die 
Transkriptionsfaktoren p53 und p73 gehören. Die Proteine üben unterschiedliche 
Aufgaben innerhalb der Zelle aus, wobei sie in bestimmten Fällen miteinander in 
biologischen Prozessen involviert sind oder die Funktion des jeweils anderen 
Proteins übernehmen können. P53, welches in ungefähr 70 % aller menschlichen 
Tumore direkt oder indirekt bezüglich seiner Funktionalität, Struktur oder 
Regulation betroffen ist, gilt als essentiell für die Tumorsuppression. Im 
Gegensatz zu p63 und p73 ist p53 auch ein häufiges Ziel von Onkoviren. Auch 
zeigt sich anhand der unterschiedlichen Phänotypen der verschiedenen knockout 
Mäuse, dass p53, p63 und p73 in unterschiedlichen biologischen Vorgängen 
involviert sind. Knockout Mäuse für p53 zeigen eine normale Entwicklung, neigen 
jedoch im Vergleich zu Wildtyp-Mäusen relativ früh zu vermehrter Tumorbildung, 
während eine Deletion von p73 schwere Folgen für die Entwicklung, besonders 
des Nervensystems, hat. Eine Deletion von p63 führt zu anderen schweren 
Entwicklungsschäden, vor allem des Epithelgewebes, und führt zum Tod binnen 
weniger Stunden nach der Geburt durch Herzinfarkt. 
Fehlbildungen von Extremitäten oder Epithelstrukturen treten auch bei mehreren 
menschlichen Krankheiten auf (ectodactylyl ectodermal dysplasia-clefting; limb 
mammary syndrome; ankyloblepharon-ectodermal dysplasia-clefting syndrome; 
split hand/foot malformation). Diese hängen mit heterozygoten Mutationen in der 
für p63 codierenden Genregion zusammen, wobei diese Mutationen 
Auswirkungen auf die Funktion und Struktur wichtiger Sekundärstrukturelemente 
haben. In Sekundärstrukturelementen bestehen strukturelle Homologien 
innerhalb der p53-Familie. Es ist jedoch zu beachten, dass für p63 und p73 
aufgrund der Genstrukturen viele verschiedene Isoformen möglich sind. Für p63 
sind daher mindestens sechs verschiedene Isoformen möglich, wobei die längste 
Isoform TAp63α aus insgesamt sechs Domänen besteht. Diese Domänen, vom 
N-terminus angefangen, sind die Transaktivierungsdomäne (TA), die DNA-Binde-
Domäne (DBD), die Oligomerisierungsdomäne (OD), die SAM- (Sterile alpha 
motif) Domäne, die QP- (Glutamine and Proline rich region) Domäne und die 
Transaktivierungs-inhibierende Domäne (TID). Weiterhin gibt es am C-terminus 
  11von TAp63α noch eine Sumoylierungsstelle. Die verschiedenen Isoformen 
können über die Oligomerisierungsdomäne miteinander wechselwirken. In 
durchgeführten Studien bildeten isolierte Oligomerisierungsdomänen von p63 
Tetramere (Dimer von Dimeren). Daher wird ein Vorliegen von p63 in der Zelle 
als Tetramer, wobei sowohl Homo-Tetramere einer einzigen Isoform als auch 
Hetero-Tetramere zweier unterschiedlicher Isoformen möglich sind. 
Zwei der Isoformen von p63 sind in wichtige biologische Vorgänge involviert. 
TAp63α, die längste Isoform, ist wichtig für die genetische Integrität von Oocyten 
in Mäusen und nimmt dort eine vergleichbare Rolle wie p53 in somatischen 
Zellen wahr. Die andere wichtige Isoform ist ΔNp63α. Diese Isoform verfügt nicht 
über die N-terminale Transaktivierungsdomäne (TA) und ist in basalem 
Epithelgewebe sehr stark exprimiert. Dort ist sie für die Erhaltung des dortigen 
Stammzellenpooles essentiell. Beide α-Isoformen verfügen C-terminal über die 
SAM-Domäne und die TI-Domäne. Besonders die TI-Domäne spielt für die 
Regulation des Proteins eine wichtige Rolle, wie in der Vergangenheit anhand 
von Deletionsstudien gezeigt werden konnte. Diese zeigten auch, dass in dieser 
Region wohl zwei unterschiedliche Funktionen lokalisiert sind. In TAp63α scheint 
die TI-Domäne intramolekular die TA-Domäne zu binden und damit zu 
inaktivieren, während ΔNp63α mit Hilfe der freien TI-Domäne intermolekular 
inhibierend wirken kann. Da angenommen wird, dass p63 als Tetramer in der 
Zelle vorliegt, findet die inhibierende Interaktion entweder innerhalb des Dimers 
oder zwischen zwei Dimeren statt. 
Wie bereits erwähnt ist am C-terminus der p63α-Isoformen eine konservierte 
Sumoylierungssequenz lokalisiert. Sumoylierung ist ein analoger Prozess zu 
Ubiquitinierung und kann verschiedene Auswirkungen haben. Es kann 
stabilisierend, sowie destabilisierend auf das Ziel-Protein wirken. Außerdem kann 
Sumoylierung zu einer Konformationsänderung führen, wodurch Interaktionen mit 
anderen Proteinen entweder ermöglicht oder verhindert werden. Für TAp73α 
wurde gezeigt, dass Sumoylierung destabilisierend wirkt. Ebenfalls wurde 
Sumoylierung von TAp63α nachgewiesen. 
Diese Doktorarbeit befasst sich hauptsächlich mit der Analyse des C-terminus in 
den α-Isoformen von p63. Hierfür wurde eine umfangreiche Mutationsanalyse in 
der TI-Domäne von TAp63α durchgeführt, wobei die Auswirkungen auf die 
  12transkriptionelle Aktivität von TAp63α und die inhibitorische Fähigkeit von 
ΔNp63α experimentell bestimmt wurden. Es wurden Reporterassays in SAOS2-
Zellen durchgeführt, wobei auf zwei unterschiedlichen Promotoren (p21 und bax) 
die transkriptionelle Aktivität von TAp63α-Konstrukten bestimmt wurde. Hierbei 
wurde eine Region innerhalb der TID identifiziert, in welcher eine zum Wildtyp 
erhöhte transkriptionelle Aktivität festzustellen war. Diese Region, in der sich 
auch mehrere konservierte Aminosäuren befinden, beginnt mit der Aminosäure 
F605. Durch Bestimmung der intrazellulären Proteinkonzentration für jedes 
analysierte Konstrukt konnten die transkriptionellen Aktivitäten um 
Konzentrationseffekte bereinigt und damit normalisiert werden. Die daraus 
resultierenden Ergebnisse bestätigten bzw. verstärkten den zuvor erkennbaren 
Trend aus den relativen Aktivitäten ohne Berücksichtigung der 
Proteinkonzentration. In diesen hatte eine Folge von 13 Aminosäuren, beginnend 
mit der Aminosäure F605, Auswirkungen auf die transkriptionelle Aktivität des 
Proteins. Durch Berücksichtigung der Proteinkonzentration wurde außerdem 
deutlich das Mutationen, welche die Sumoylierungsstelle betreffen, nur einen 
Einfluss auf eben jene Proteinkonzentration haben, jedoch nicht auf die 
intrinsische Aktivität des Proteins. Um diesen Punkt weiter zu überprüfen, wurde 
eine weitere Mutationsreihe durchgeführt, in welcher die zuvor untersuchten 
Konstrukte zusätzlich eine Mutation an der Sumoylierungsstelle tragen. Die nicht 
auf die Proteinkonzentration normalisierten Aktivitäten auf dem p21-Promoter 
waren bei diesen Konstrukten meist erhöht. Nach der Normalisierung waren die 
Aktivitäten jedoch auf einem ähnlichen Niveau wie die der Mutationsreihe im 
vorherigen Experiment ohne Mutation an der Sumoylierungsstelle. Hierdurch 
werden zwei voneinander getrennte Möglichkeiten der Regulation von TAp63α 
deutlich. Zum einen ein intrinsischer Mechanismus (TA-TI), welcher 
wahrscheinlich über post-translationale Modifikationen reguliert wird. Zum 
anderen die Sumoylierung, welche die Konzentration des Proteins beeinflusst. 
Dieselben Experimente wurden auch auf dem bax-Promoter durchgeführt, wobei 
die zusätzliche Mutation der Sumoylierungsstelle meist keinen Effekt bei den 
nicht normalisierten Aktivitäten hatte. Durch Normalisierung ergab sich jedoch 
erneut ein ähnliches Bild der transkriptionellen Aktivitäten wie auf dem p21-
Promoter. Regulation durch Sumoylierung scheint daher Promoter-abhängig zu 
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sowohl aktive als auch inaktive p63 Varianten im Zellkern lokalisiert sind, 
eventuelle Aktivitätsunterschiede also nicht durch Translokalisation zustande 
kommen. 
Ein weiteres Experiment sollte klären, ob geringe Proteinkonzentrationen im 
Zusammenhang mit erhöhter transkriptioneller Aktivität stehen. Hierzu wurde ein 
aktives Konstrukt, welches in den Zellen in niedriger Konzentration vorliegt, mit 
einer zusätzlichen Mutation in der DBD (DNA binding domain) versehen. Diese 
inaktive Variante ist in einer ähnlichen Konzentration wie der Wildtyp von TAp63α 
nachweisbar. Eine hohe transkriptionelle Aktivität hängt im Fall der 
durchgeführten Experimente als auch in anderen Fällen mit einer niedrigen 
Proteinkonzentration in der Zelle zusammen und Regulation findet wohl statt, 
wenn ein aktives Protein an einen Promoter bindet bzw. an einem späteren Punkt 
wie z.B. der Transaktivierung. 
Die durchgeführten Ergebnisse zeigen, dass für die Autoinhibition von TAp63α 
eine Folge von Aminosäuren eine wichtige Rolle spielt. Hierbei hat besonders die 
Mutation der drei Aminosäuren, F605, T606 und L607 zu Alanin signifikante 
Auswirkungen. Das Threonin innerhalb dieser drei Aminosäuren ist zwischen 
Spezies unterschiedlicher evolutionärer Entwicklungsschritte vollständig 
konserviert. Diese Aminosäure dient womöglich als Akzeptor für 
Phosphorylierung oder anderer Modifikationen. Ein Experiment, in welchen das 
Threonin zu einem Glutamat mutiert wurde um eine Phosphorylierung zu 
simulieren, brachte jedoch kein signifikantes Ergebnis. Dies kann verschiedene 
Ursachen haben u.a. ist es wahrscheinlich, dass Glutamat kein gutes 
Phosphorylierungsanaloga im Fall von Threonin darstellt. 
Die identifizierten Reste scheinen wichtig für die Funktion bzw. die Struktur des 
Proteins zu sein, da in biophysikalischen Experimenten ebenso deutliche 
Auswirkungen auf die intramolekularen Wechselwirkungen zwischen TA- und TI-
Domäne durch analoge Mutationen gezeigt werden konnten. Für TAp63α ist 
daher eine Signifikanz dieser Ergebnisse bezüglich der Regulation und 
möglicherweise der Struktur anzunehmen. Über Modifikationen an den 
identifizierten Resten könnte das Protein eine offene und damit aktive 
Konformation einnehmen. Auslöser könnte ein Signalweg sein, bei welchem eine 
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beispielsweise in Oocyten der Maus bei DNA-Doppelstrangbrüchen aktiviert 
werden, da in diesem Fall TAp63α phosphoryliert wird. 
Die vorgestellten Ergebnisse geben einen Hinweis auf welche Weise TAp63α 
aktiviert werden könnte. Um zu analysieren, ob die gleichen Aminosäuren 
Auswirkungen auf die Funktion von ΔNp63α haben, wurde eine analoge 
Mutagenese der erwähnten Aminosäuren FTL in ΔNp63α durchgeführt. Da 
ΔNp63α auf dem p21-Promoter inaktiv ist, wurde ein Inhibierungsexperiment 
durchgeführt, um eventuelle Auswirkungen festzustellen. Auf die transkriptionelle 
Aktivität der aktivsten Isoform TAp63γ wirkt ΔNp63α inhibierend. Dies geschieht 
zum einen durch direkte Inhibition über die Bildung von Hetero-Tetrameren und 
der daraus resultierenden Interaktion der freien TA-Domänen (TAp63γ) und der 
freien TI-Domänen (ΔNp63α). 
Außerdem findet eine indirekte Inhibition statt, indem Homo-Tetramere von 
ΔNp63α an den Zielpromoter binden und so für andere aktive Tetramere 
blockieren (Promoter squelching). In einem Reporterassay wurden zunächst 
SAOS2- Zellen mit unterschiedlichen Plasmidkonzentrationen von ΔNp63α und 
einer jeweils immer gleichen Menge TAp63γ−Plasmid co-transfiziert. Die 
Proteinkonzentrationen wurden mittels Western Blot ermittelt. 
Es zeigte sich, dass der größte Teil der Inhibierung der transkriptionellen Aktivität 
von TAp63γ durch ΔNp63α über direkte Inhibition (TA-TI-Interaktion) zustande 
kommt. Diese direkten inhibitorischen Fähigkeiten von ΔNp63α zeigten 
erhebliche Einbußen, wenn die Aminosäuren FTL in der TI-Domäne zu Alanin 
mutiert wurden, was auch auf TAp63α signifikante Auswirkungen hatte. Jedoch 
gibt es einen entgegen gesetzten Effekt bei der indirekten Inhibition, da sich die 
Fähigkeit zur DNA-Bindung anscheinend durch die Mutation von FTL verbessert, 
was auf eine offenere Konformation des Proteins hindeuten könnte. Ähnliches 
lässt sich auch im Fall von TAp63α vermuten. Dies deutet auf die Wichtigkeit 
jener in dieser Doktorarbeit identifizierten Aminosäuren FTL für die Regulation 
und Struktur beider Isoformen hin. Die Mutation dieser Aminosäuren führt 
vermutlich zu einem Aufbrechen von Interaktionen und damit zu der erwähnten 
offeneren Konformation. Aufgrund der Inhibierungsassays lässt sich auch 
vermuten, dass eine Tetramerisierung eventuell für die volle transkriptionelle 
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ist anzunehmen, dass TAp63γ vornehmlich in gemischten Tetrameren zwischen 
TAp63γ und ΔNp63α, vorliegt. Eine Doppelmutation (DBD + TID) in ΔNp63α 
führte im Inhibierungsexperiment dazu, dass diese inaktive Isoform nicht mehr 
inhibierend über DNA-Bindung oder TA-TI Interaktion wirken kann, sondern nur 
noch über die Bildung von Hetero-Oligomeren. Diese haben die gleiche Aktivität 
wie ein TAp63γ-Konstrukt, welches nur noch Dimere bilden kann. Dies deutet auf 
die Wichtigkeit des Oligomerisierungszustandes hin. 
Es besteht die Möglichkeit die Wildtypen von TAp63γ und ΔNp63α durch 
gegenseitige Expression und der daraus resultierenden Bildung von Hetero-
Oligomeren zu regulieren. 
Im Fall von TAp63α und ΔNp63α wäre die Regulation über Modifikation in der TI-
Domäne oder über Sumoylierung unabhängig von anderen Isoformen. Da 
TAp63γ weder über die TI-Domäne noch über eine bekannte Sumoylierungsstelle 
verfügt sind diese Regulationsmechanismen der α-Isoformen für   
TAp63γ ausgeschlossen. Jedoch könnte, analog zur Regulation von TAp63α, die 
Aktivität von TAp63γ über posttranslationale Modifikationen zu steuern. Daher 
wurde für TAp63γ, auch wenn noch keine biologische Funktion feststeht, eine 
Deletionsstudie des C-terminus durchgeführt. 
Auch in diesem Fall wurden Aminosäuren identifiziert, die die transkriptionelle 
Aktivität des Proteins beeinflussen. Hierbei handelt es sich um ein Threonin und 
ein Serin, die, wenn sie fehlen oder zu Alanin mutiert sind, einen signifikanten 
Abfall der transkriptionellen Aktivität des Proteins verursachen. Eine Mutation 
führt in jedem Fall zur Inaktivität, während die Inaktivität nach Deletion 
Einschränkungen unterworfen ist. Diese Ergebnisse müssen nicht zwangsläufig 
bedeuten, dass auch am C-terminus von TAp63γ ein Kontrollelement lokalisiert 
ist, sondern können nur darauf hinweisen, dass diese Aminosäuren essentiell für 
die Funktion des Proteins sind. Eventuell liegen die erwähnten Aminosäuren in 
der Zelle phosphoryliert und damit TAp63γ im aktiven Zustand vor. Dies würde 
auch erklären, warum eine Mutation dieser Aminosäuren zu Inaktivität des 
Proteins führt. In jedem Fall hat eine Modifikation am C-terminus von TAp63γ 
Auswirkungen auf die Aktivität und diese Implikationen werden durch zwei 
Aminosäuren verursacht. Somit gibt es am C-terminus beider untersuchten TA-
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Isoform haben. Des Weiteren sind dieselben Aminosäuren, welche die 
transkriptionelle Aktivität von TAp63α beeinflussen, wichtig für die Fähigkeit von 
ΔNp63α die aktivste Isoform TAp63γ zu inhibieren. 
Wie bereits erwähnt, spielt ΔNp63α eine wichtige Rolle für die Entwicklung von 
Epithelgewebe. Wie sich in einem Experiment zur Genexpression verschiedener 
Gene zeigte, welche in der Osteogenese involviert sind, hat die Überexpression 
von  ΔNp63α dort deutliche Auswirkungen. In diesem Fall scheint es 
wahrscheinlich, dass die jeweiligen Promotoren durch ΔNp63α blockiert werden 
(Promoter squelching) und keine direkte Interaktion mit anderen Proteinen 
stattfindet, was weitere Experimente zeigen könnten. Es gilt vor allem zu 
beachten, dass ΔNp63α im vorliegenden Fall überexprimiert vorliegt. Unter 
zellulären Bedingungen wäre die Konzentration von ΔNp63α wohl nicht derart 
erhöht und für ein vollständiges Blockieren der Ziel Promotoren vermutlich nicht 
ausreichend. Jedoch ist es denkbar ein Blockieren der Ziel-Promotoren bei 
niedrigerer Proteinkonzentration über eine erhöhte Affinität von ΔNp63α zu DNA 
zu ereichen. Für eine Kontrolle der Genexpression über Promoterbindung von 
ΔNp63α, würde der mögliche identifizierte Regulationsmechanismus 
Auswirkungen haben, da eine „aktivierte“ Form von ΔNp63α eventuell eine 
höhere Affinität zur DNA besitzt. Dies wäre eine Möglichkeit über die ΔNp63α 
reguliert werden könnte, unabhängig von der Interaktion mit anderen Isoformen 
von p63. Experimente könnten diese Hypothese zur Regulation von ΔNp63α 
bestätigen. Wie auch im Fall von TAp63α könnten weitere Untersuchungen 
zeigen, ob eine der identifizierten Aminosäuren durch zelluläre Signale modifiziert 
wird, wie z.B. bei DNA-Schäden in Oocyten. 
 
 
 
 
 
 
 
  173. Introduction 
 
3.1 The p53-family 
 
The p53-family consists of three transcription factors, p53, p63 and p73, which 
share structural [Fig. 1] and to some extend functional similarity [1,2]. Because of 
this similarity p63 and p73 can regulate p53 target genes and have been 
implicated in p53-dependent apoptosis [3,4]. The merging of the three proteins to 
a p53-superfamily of transcription factors started after the identification of the 
genes for p63 and p73 in 1997 and 1998 [5-8]. The p53 gene was the first tumor 
suppressor gene to be identified and has been first described in 1979 [9]. The 
biological role of p53 is tumor-suppression by cell cycle arrest and apoptosis. 
Approximately 70% of all human cancers are linked to misfunction of p53, either 
by mutations in the p53 gene or indirect inactivation [9-12]. Mice with a p53 
knockout develop normally, but have a highly increased rate of tumorigenesis 
[13]. Thus p53 is known as the “guardian of the genome” [14]. 
P63 and p73 show high sequence homology to p53 and to each other [Fig. 1], 
especially in certain structural elements, like the DNA binding domain (DBD) or 
the oligomerization domain (OD), but p63 and p73 both have additional structural 
elements after the oligomerization domain, which might be important for their 
structure,  functionality and regulation [15,16]. 
 
 
Figure 1: Domain structures of the p53 family members (full length isoforms) and sequence 
identities. TA, transactivation domain; Oligo, oligomerization domain; SAM, sterile alpha motif 
domain; PS, post-SAM. [taken from ref. 1, modified]. 
 
 
 
  183.1.1 One family – different functions 
 
The main function of p63 and p73 seems not to be tumor suppression as the 
knockout mice show totally different phenotypes than the p53 knockout mice 
[13,17-20]. Also most tumor virus proteins only target p53 [21-25]. For p73 the 
knockout mice show developmental defects, including hippocampal dysgenesis 
and hydrocephalus due to hypersecretion of cerebrospinal fluid in addition to 
purulent respiratory infections, also their reproductive and social behaviour is 
abnormal as a result of dysfunctional pheromone pathways [19,20]. Therefore 
p73 seems to be essential for the development of the central nervous system. 
Also it seems to be essential for preventing neurodegeneration [26]. 
P63, despite the structural similarity to p73, is essential for other biological 
developmental and differentiation processes than p73. The knockout-mice for p63 
show severe defects including limb truncations and lack of all squamous epithelia 
and die within a few hours after birth [Fig. 2] [17,18].  
Figure 2: Comparison of a p63-knockout mouse (-/-) with a wt mouse 
(+/+).  The knockout mouse shows severe developmental defects, 
especially in extremities and epithelial structures. [taken from ref. 17] 
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to spontaneous or chemically induced tumors [27]. Therefore p63 has been 
assigned a crucial role in epithelial stem cell biology [17,18,28-31]. Recent 
findings also show that p63 is essential for the surveillance of the genetic stability 
of murine Oocytes [32]. Also there is emerging evidence that p63 is regulating 
neuronal cell survival together with p53 and p73 [33]. Taken together p63 seems 
to be important in various biological pathways and its function is different to the 
functions of p53 and p73. Nevertheless these proteins might act together in some 
pathways or might be able to substitute each other in some cases. 
 
 
3.2 p63 
 
3.2.1. Nomenclature 
The main topic of this thesis is p63. Different names has been assigned to this 
protein throughout the years. It is also known as transformation related protein 63 
(TP63), tumor protein p73 like (P73L), p51, p40, Keratinocyte transcription factor 
KET or Chronic ulcerative stomatitis protein CUSP. 
 
 
3.2.2 Gene structure and isoforms 
 
The gene of p63 has been identified and characterized in 1997 and 1998 [6, 17, 
18]. Due to the exon structure of the p63 gene [Fig. 3] six different splicing 
variants of p63 exist [6]. 
 
 
Figure 3: Exon structure of the p63 gene (coding sequences in black). The two promoters 
are indicated as arrows. Splicing combinations are indicated as beta and gamma, alpha is the full 
length isoform. [taken from ref. 6] 
 
  20The gene structure with two promoters combined with three alternative splicing 
variants leads to six different isoforms [Fig. 4]. 
 
 
Figure 4: Domain structure of the p63 isoforms. (TA, transactivation domain; DBD, DNA 
binding domain; OD, oligomerization domain; QP, glutamine and proline rich domain; SAM, sterile 
alpha motif; TI, Transactivation inhibitory domain; K, sumoylation site IKEE). 
 
The transcriptional activities of the six isoforms in cell culture experiments are 
different. The ΔN isoforms show no transcriptional activity on most promoters, the 
three isoforms with the transactivation domain TAp63β and TAp63γ are 
constitutively active on promoters like p21,  mdm2 and bax while TAp63α is 
inactive, which is achieved by an auto-inhibitory element located at the C-
terminus (TI domain) [6,15]. The same element is responsible for the strong 
inhibitory potential of ΔNp63α [6]. 
 
 
3.2.3 Biological relevance 
 
The two α-isoforms have been assigned to critical biological functions [17,18,32]. 
  21TAp63α, the largest isoform, is expressed in murine Oocytes, where it is essential 
for a p53 independent manner of apoptosis induced by DNA damage and 
therefore monitors the integrity of the female germ line [32]. Oocytes stay 
arrested in the prophase of meiosis I (dictyate arrest) during oogenesis until they 
are recruited for ovulation, a period which can last up to several decades in 
humans. In the arrested cells Tap63α is highly expressed and mice experiments 
showed that it is transcriptionally inhibited [32]. After an exposure to ionizing 
radiation the binding affinity of p63 to DNA increased ~20 fold and this increase 
was accompanied by p63-phosphorylation and death of the irradiated oocytes. 
Therefore TAp63α seems to be crucial for the integrity of the female germline. 
The other biologically important isoform ΔNp63α which lacks the N-terminal 
transactivation domain is highly expressed in the basal layer of epithelial tissue 
[17]. It seems to be involved in processes maintaining the regenerative potential 
of epithelial stem cells explaining the defects in p63 knockout mice as loss of 
regenerative potential of cells. 
Both isoforms essential for these biological processes, ΔNp63α and TAp63α, 
have a non-truncated C-terminus (α-isoforms). The domains localized there are 
the SAM-Domain (SAM, sterile alpha motif), the TI- (transactivation inhibitory) 
domain and the sumoylation site (amino acid sequence IKEE). 
TAp63 is assumed to be a tetrameric protein, the OD for itself forms dimers of 
dimers [16]. Therefore the inhibiting interaction between the TI and TA domain 
could take place between two monomers within a dimer or between two dimers 
within a tetramere. The oligomeric state might be important for the regulation of 
the protein. In TAp63α the C-terminal domain and its interaction within the protein 
or between two proteins might lead to a closed conformation of the protein and 
therefore less ability to bind DNA. A previous study mapped the TID to the last 
~70 amino acids and showed that the domain contains of two different sub-
domains which both contribute to inhibition in a different manner, one of them 
located in the first 45 amino acids of the TID and the second in the last 25 amino 
acids [15]. These regions are further investigated in this thesis. 
Besides the lethal effect of a deletion of the p63 gene in mice mentioned before, 
there are also human syndromes associated with germline mutations of p63 
causing limb defects and ectodermal dysplasia, such as Ectrodactyly Ectodermal-
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Limb-Mammary Syndrome (LMS), Hay-Wells syndrome or Ankyloblepharon 
(AEC), Acro-Dermato-Ungual-Lacrimal-Tooth malformation (ADULT) and Rapp-
Hodgkin Syndrome [34,35]. The occurred mutations are heterozygous and might 
act as gain of function or dominant-negative allele rather than by haploinsuffiency. 
For EEC mostly all mutations were substitutions of amino acids in the DNA 
binding domain [36]. Only 10% of SHFM patients carried mutations with variable 
effects on DNA binding, frameshift mutations were located in exon 13 and 14 in 
the case of LMS, which leads to a truncated protein lacking the TID and partially 
the SAM domain exclusively in the α-isoforms [37]. The Hay-Wells syndrome on 
the other hand is caused by missense mutations in the SAM domain, which might 
affect protein-protein interactions [38]. The ADULT syndrome seems to be 
caused by mutations which affect only the ΔN isoforms, but one patient was 
found, which had an mutation in the region of the DBD [39, 40]. Taken together, 
the mutations found in these syndromes are localized in the DBD or SAM domain. 
A lot of these mutations can be also found in inactive p53 mutants [41]. 
 
 
3.3. Regulation 
 
3.3.1 Regulation of p53 
 
Transcription factors can be regulated by post-translational changes i.e. 
phosphorylation, acetylation, glycosylation, ubiquitination or lipid modification [42]. 
One regulation mechanism for the family member p53 is via the interaction with 
the ubiquitin E3 ligase Mdm2 [Fig 5] which leads to a short half life of the protein 
between 20 min and 2 hours [9,43,44]. Ubiquitin, a 76 AA polypeptide, is 
covalently linked to lysine residues on target proteins by an enzymatic cascade, 
which targets the protein for degradation in the proteosomal pathway [45]. Mdm2 
binds to the transactivation domain of p53 which leads to poly-ubiquitination of 
the protein and proteosomal degradation [42,43,46,47]. The regulation of p53 is 
achieved by the ratio of the concentrations of Mdm2 and p53, which is modulated 
by the Mdm2 homologue Mdm4 [43,48]. If cellular stress such as DNA-double 
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Figure 5: Regulation of p53 [taken from ref. 43]. In an unstressed cell p53 gets 
ubiquitinated and degraded, while cellular stress leads to phosphorylation of p53 
leading to a transcription of target genes. 
 
strand brakes i.e. after ionising radiation occur several kinases like DNA-PK (DNA 
dependent protein kinase), ATM (Ataxia Teleangiectasia Mutated) or Checkpoint- 
dependent kinases (Chk) phosphorylate p53 at the sites crucial for the Mdm2 
interaction which leads to an accumulation and activation of p53 [43,44,49,50]. 
Also involved in p53 regulation is the prolyl isomerase  Pin1, which induces a 
conformational change in p53 as response to stress signals and also seems to be 
involved in the regulation of p73 [51,52]. 
 
 
3.3.2 The TID in p63α 
 
 Even though the p63-dependent apoptotic pathway in murine oocytes might be 
  24similar to the p53-dependent in somatic cells the regulation of p63 seems to be 
more complicated due to the different isoforms. As mentioned before the C-
terminus of the α isoforms acts as an transactivation inhibitory domain [15]. 
Therefore the full length isoform TAp63α is inactive because of the intramolecular 
inhibition. The second isoform harbouring the TI domain, ΔNp63α, is capable of 
inhibiting other isoforms [6]. The TI-domain and its conserved amino acids are 
shown in Fig. 6. 
 
Figure 6: Sequence alignment of C-terminal p63α sequences of various vertebrate and 
invertebrate species. Sequences N-terminal to the SAM domain to the end of the protein are 
shown. The sequences of the SAM domains themselves are not displayed. Strictly conserved 
amino acids are labelled red. The conserved KEE sumoylation motif is labelled in blue. This 
sumoylation sequence is located N-terminal to the SAM domain in invertebrate species [taken 
from ref. 53]. 
 
Even though the possible function of the TID has been shown, the important 
amino acids of this function were unknown. In this thesis data is presented about 
the amino acids in the TI domain, which seem to be important for the function of 
the TID and its inhibitory interaction. A region is identified, where mutations have 
significant effects on transcriptional activity of TAp63α. Additionally, If these 
amino acids are mutated in ΔNp63α it looses its inhibitory abilities. As mentioned 
before ΔNp63α plays an important role in epithelial development and possible 
implications on its function might be significant for these biological processes. In 
the natural state these amino acids might be involved in a control mechanism. It 
is also possible that transcriptional activity might be controlled by concentrations 
  25of the different isoforms. 
 
 
3.3.3 Sumoylation 
 
Another regulation mechanism of p63 is sumoylation, which is an ubiquitination 
like mechanism [54]. As mentioned before p53 protein levels are tightly controlled 
by Mdm2, which is an ubiquitin ligase and promotes rapid degradation via the 
proteasome pathway [42,43,47,48,49].  At the C-terminus of human TAp63α a 
classical sumoylation sequence is located and sumoylation was shown for both 
TAp63α and TAp73α [54-56]. SUMO-1 (small ubiquitin-like modifier 1] is a 
ubiquitin-like tagging polypeptide and modifies a large number of proteins. It is 
attached to the lysine in the sumoylation sequence by a similar enzymatic system 
like ubiquitin, [57,58]. This can lead to degradation as well as stabilization of the 
target protein, also it can have effects on interactions of the target protein [Fig. 6] 
[58-64].  
 
 
Figure 7: Consequences of SUMO-1 attachment (detachment). A: Degradation; B: 
Stabilization; C: Conformational change; D, (E): Providing binding site. 
 
  26Modification of p73α by SUMO-1 seems to destabilize the protein [33]. The 
sumoylation site in TAp63α or its homologues is conserved throughout various 
organisms as well as some amino acids within the TID [Fig 6]. The sumoylation 
site is located at different positions in vertebrates and invertebrates but remained 
conserved. 
Additional to the extensive mutational analysis that was carried out throughout the 
whole TI domain to identify the important amino acids, the implications of a 
mutation of the sumoylation site was analyzed and if both sites are independent 
from each other.  
 
 
3.3.4 Oligomerization state and regulation of TAp63γ 
 
Another important question regarding the function and regulation of p63 is its 
oligomerization state. The oligomerization domains of human p63, as well as p73 
and p53 can form stable homo tetrameres or the different splicing forms can 
interact with each other via the oligomerization domain and form hetero 
tetrameres [65, 66]. Interestingly the amino acids in the oligomerization domain 
are not as highly conserved as i.e. in the DNA binding domain. Some stabilizing 
structural elements, like the SAM domain, might be necessary to keep it in its 
tetrameric state [16]. An isoform without the SAM and the TI domain and with a 
different C-terminus than TAp63α is TAp63γ, which is also the most active 
isoform of p63 [6,15]. Its structural organization looks similar to that of p53. Its 
regulation has to be different than that of TAp63α due to the missing TID, but at 
the C-terminus of TAp63γ there might also be a control element. The C-terminus 
of TAp63γ is also a part of this thesis as well as consequences of the oligomeric 
state on the transcriptional activity. 
 
 
3.2.4 Target genes of p63 
 
Many potential target genes for p63 involved in different cellular actions have 
been identified by various techniques [67]. Two of the identified target genes are 
  27bax and p21 [68,69]. Therefore the promoters of these genes have been used for 
analysis of the transcriptional activity of p63 in this thesis. Also the promoter of 
the Vitamin-D receptor (VDR) gene was identified as a target of p63 [70].  The 
VDR as a ligand dependent transcription factor is important for differentiation of 
keratinocytes and osetoblasts [71,72]. In this thesis data is shown about the 
implications of the different p63 isoforms on genes involved in osteogenesis 
(VDR, Osteopontin, Osteocalcin, Collagene). It has been shown that for several 
proteins, like VEGF (Vascular endothelial growth factor), the ΔN and TA forms of 
p63 have different or opposite effects on expression of the proteins [73,74]. There 
are also other reported target genes, which seem to act together with p63 in one 
pathway. One of them is the IκB kinase-α (IKK-α), which seems to be a direct 
downstream target of p63 [75]. As mentioned before p63 plays a major role in the 
development of epidermal tissue [17,18,28-31]. The cells responsible for 
regeneration of this multi-layered, stratified epithelium are terminally 
keratinocytes, which are continuously differentiating [76-78]. IKK-α is essential for 
the formation of the epidermis and the knockout mice for IKK-α look very similar 
to those of p63 and show very similar syndromes [79-82]. The important question 
is, how p63 is regulated to activate or inactivate genes involved in various 
biological pathways and which isoforms are regulated in which way. 
 
 
  284. Materials 
 
4.1 Reagents 
 
Reagents were purchased by Carl Roth GmbH. Exceptions are listed below. 
 
Bovine serum albumin (BSA)        Sigma 
Complete mini EDTA-free protease inhibitors    Roche  
Coomassie Brillant Blue R250         Sigma  
Desoxynucleosid-5‘-triphosphate (dNTPs)      NEB 
Ethylenediaminetetraacetc acid (EDTA / 100 X)  Pierce 
Halt™ Protease inhibitor cocktail (100 X)    Pierce 
Hoechst  fluorochrome  33278     Sigma 
Mammalian Protein Extraction Reagent (M-PER)  Pierce 
Non-fat  dry  milk  powder        Fluka 
Trypsin-EDTA         PAA 
T w e e n 2 0         S i g m a  
 
 
4.2 Enzymes 
 
Accutase        PAA 
D N A s e   I         S i g m a  
Lyzozyme        Sigma 
Phusion  DNA  Polymerase      Finnzymes 
Proteinase  K        Invitrogen 
Restriction  enzymes        NEB   
R N a s e   A           S i g m a    
T4-DNA-ligase         NEB 
Tev  Proteinase       Institute 
Turbo Pfu DNA Polymerase        Stratagene 
Vent  DNA  Polymerase      NEB 
 
  294.3 Media + additives 
 
Ampicillin        Carl  Roth 
Chloramphenicol       Carl  Roth 
Dulbecco’s modified Eagle’s media (DMEM)     PAA 
Epression  Media  (2XYT)      Institute 
Fetal  bovine  serum  (FBS)      PAA 
Kanamycin        Carl  Roth 
LB  (Lysogeny  broth)     Institute 
LB  plates       Institute 
L-Glutamine  (200  mM)      PAA 
Penicillin-streptomycin (100U/ml and 100μg/ml)   PAA 
SOC (Super Optimal Broth + Glucose media)  Institute 
 
 
4.4 Ladders 
 
Gene Ruler 1 kb DNA Ladder         Fermentas  
Kaleidoscope Protein Ladder Prestained      Bio-Rad  
Benchmark Protein Ladder         Invitrogen  
 
 
4.5 Antibodies 
 
Primary antibodies: 
 Anti-myc  4A6     Millipore 
 Anti-GAPDH  (Glyceraldehyde-3-phosphate 
 dehydrogenase      Millipore 
 Anti-myc  9E10  Cy3      Sigma 
Secondary antibodies: 
  Anti-mouse HRP (Horseradish peroxidase)   Sigma 
 
 
  304.6 Materials 
 
Materials were purchased by Carl Roth GmbH. Exceptions are listed below. 
 
Coverslips          VWR 
Cryotuber        Nalgene 
Culture  flasks      Greiner  Bio  One 
Gel  blotting  paper       VWR 
Glaswares  und  Glaspipettes     Fisher  Scientific 
Nitrile Gloves Safeskin  Kimberly-Clark 
PVDF  membrane         Millipore     
Parafilm        American  National  Can 
Pipette tips 20 µl, 200 µl, 1000 µl       Omnitip 
Novex  gels        Invitrogen 
Well  plates  (black)       Greiner  Bio  One 
Well  plates  (Luminescence)     PAA 
Plastic  ware          Sarstedt,  Greiner 
Ni
+-NTA-column     GE 
Gelfiltration column Superdex 200      GE 
 
 
4.7 Kits   
 
Dual-Glo  Luciferase  Assay    Promega 
Effectene®  Transfection  reagent     Qiagen 
Endofree® Plasmid Buffer Set + Tip 100    Qiagen 
Mycosplasma PCR Test Kit        Applichem 
Nucleospin®  Plasmid      Macherey  Nagel 
QIAquick Gel Extraction Kit         Qiagen 
QIAquick PCR Purification Kit         Qiagen 
QuikChange® Site-Directed Mutagenesis Kit     Stratagene  
RT-PCR Kit Cellsdirect
TM      Invitrogen 
 
 
  314.8 Centrifuges 
 
HERAEUS Biofuge 13 
HERAEUS Minifuge GL 
EPPENDORF Centrifuge 5417 R 
EPPENDORF Centrifuge 5810 R 
Sorvall Biofuge 13 Evolution RC 
Sorvall Biofuge 13 RC-5B 
 
 
4.9 Instruments 
 
Äkta-Protein purification system     Amersham  Biosciences 
Analytical  balance       Sartorius   
Autoclave        Getinge 
Axiocam  MRm         Zeiss   
B a l a n c e         M e t t l e r   T o l e d o  
Clean  Bench  Herasafe      Kendro 
Counting  chamber       Carl  Roth 
Fluorescence microscope Axiovert 200      Zeiss 
Freezer  –20°C  Profiline      Liebherr 
Freezer  –80°C  Profiline      Liebherr 
Gel Imager        B i o m e t r a  
Heatable magnetic stirrer Ikamak     IKA-Labortechnik 
Heating  block              VWR 
Incubator Heracell    Heraeus 
Incubator model 400      Memmert GmbH      
Light microscope Axiovert 40 CFL      Zeiss          
Lumi  Imager  P1       Roche 
Luminescence Reader Genios Pro      Tecan 
Microwave  600  W       Alaska 
Multipipettes        Eppendorf 
N2 Dewer  GT40       L’Air  Liquide    
Nanodrop  100       peqlab 
  32NuPAGE Novex Gel system         Invitrogen   
pH-meter  PHM  210       Radiometer    
Pipettes        Eppendorf,  Abimed 
Power supply    Biometra 
Pump   HLL 
SDS-Gelelektrophoresis chamber    Biorad 
Shaker        Heidolph 
Shaking  incubator         Innova  AG 
Shaking  incubator       New  Brunswick     
Sonifier  Labsonic  U       B.  Braun 
Thermocycler      Bio-Rad,  Eppendorf 
Vakuum  pump       Abm 
Vortexer Reax 2000     Heidolph 
Waterbath          Haake 
Water treatment system Milli-Q         Millipore  
 
 
4.10 Buffers  
Buffers were adjusted to final volume with ddH20. 
 
10 x Protein Sample Buffer      10 % Glycerol 
5   % ß-Mercaptoethanole 
2  % (v/v) SDS 
0,05 % (w/v) Bromphenoleblue 
1,25 M Tris-HCl, pH 6,8 
 
2 X Protein Sample buffer       20 % 10X Protein Sample Buffer 
19 % ß-Mercaptoethanole 
 
Buffer D            50 mM Tris-HCl, pH 8.0 
20 mM NaCl 
1 mM EDTA 
1% SDS 
 
  33Coommassie brilliant blue solution     0.1% (w/v) Coomassie R250 
       40%  Methanol 
       10%  Acetic  acid 
 
Destaining  solution        40%  Methanol 
       10%  Acetic  acid 
 
DNA-Samplebuffer      50  %  Glycerol 
                    0,1%  (w/v)  Bromphenoleblue 
100 mM Tris-HCl, pH 8,0 
 
ECL1        100  mM  Tris-HCl,  pH  8.5   
                    2.5  mM  Luminol   
                       0.4 mM p-cumaric acid 
 
ECL 2             100 mM Tris-HCl, pH 8.5  
                        0.0183% H2O2 
  
 
Lysis-, Dialysisbuffer             250 mM NaCl  
250 mM KCl 
50 mM Tris-HCl, pH 8,0 
 
Mammalian cells lysis buffer      98% M-PER 
1% Protease inhibitor cocktail 
100 X (Halt™) 
1 % EDTA 100 X 
100 U DNAse I 
 
MOPS SDS running buffer       50 mM MOPS 
1 mM EDTA 
0.1 % SDS       
  50 mM Tris-HCl, pH 7,7 
      
 
  34Mounting  media      90%  Glycerol 
       100mM  Tris  pH  8.0 
 
PCR (QC) Buffers  10 X or 5 X buffers delivered by 
manufacturer 
 
P B S         1 0 m M   N a H 2PO4 
       1 0 m M   N a 2HPO4 
       1 5 0 m M   N a C l  
 
PBST        PBS  +  0.2  %  TritonX-100 
 
SDS-PAGE running buffer (10x)    1.92M  Glycine 
       0.25M  Tris  pH8.3 
 
T4-ligase buffer  10 X buffer delivered by 
manufacturer 
 
TAE  (50x)       2M  Tris-acetate 
       1 0 0 m M   E D T A  
 
TBS  (1x)       50mM  Tris   
       1 5 0 m M   N a C l  
 
TBST (1x)            1x TBS + 0.1% Tween20 
 
TE  buffer       10mM  Tris  pH8 
       1 m M   E D T A  
 
Western Blot Transfer Buffer      25 mM Bicine 
       1   m M   E D T A  
25 mM Bis-Tris, pH 7,7 
 
 
  354.11 Cells 
 
Bacterial strains 
E. coli DH5:  recA1, endA1, relA1, gyrA96, thi-1, supE44, 
U169, deoR, hsdR17 (rK-, mK+), λ-, F-, Ф80, 
lacZΔM15, Δ(lacZYA-argF) 
E. coli BL21 (DE3) simple  B, F-,  dcm ompT,  hsdS (rB- mB-) gal λ (DE3) 
E. coli BL21 lac rare    F-, ompT, hsdSB (rB-mB-), gal dcm (DE3) 
 
Mammalian cells 
Osteosarcoma cells (SAOS2) obtained from DSMZ 
 
 
4.12 Software   
 
Adobe Illustrator CS 2 
Adobe Photoshop CS 2 
AxioVision AC rel 4.5, Zeiss 
BioDocAnalyze 2.0, Biometra GmbH 
Cn3D 4.1, NCBI 
Clustal X Multiple Sequence Alignment 1.83 
Lumianalyst, Roche 
Magellan 5, Tecan 
MS Excel 2003, Microsoft 
MS Word 2003, Microsoft 
pDraw 32 1.0, Acaclone Software 
Pymol 2005, DeLano Scientific LLC 
SAPO Trace Viewer 
 
 
4.13 Oligodeoxyribonucleotides 
 
The Oligonucleotides listed in table 1 were either ordered at Biospring or MWG. 
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Oligonucleotide-
name 
Oligonucleotide sequence  Purpose 
p21outNhe_f  TTT TTT GCT AGC ACT CTT GTC CCC CAG GCT GAG 
CCT CCC 
 
pGL3-Insert 
p21outXho_r  CCC CCC CTC GAG GTC TCC TGT CTC CTA CCA TCC 
CCT TCC 
 
pGL3-Insert 
FEL_f  CGA TGC CGT GCG CTT TGA GCT CCG CCA GAC CAT 
CTC 
 
Quickchange 
FEL_r  GAG ATG GTC TGG CGG AGC TCA AAG CGC ACG GCA 
TCG 
 
Quickchange 
 
FTL->AAA_f 
GTG ATC GAT GCC GTG CGC GCT GCA GCC CGC CAG 
ACC ATC TCT TTT 
 
Quickchange 
 
FTL->AAA_r 
GAA AAG AGA TGG TCT GGC GGG CTG CAG CGC GCA 
CGG CAT CGA TCA C 
 
Quickchange 
R279H_f  CTG CGT CGG AGG AAT GAA CCA CCG TCC AAT TTT 
AAT C 
 
Quickchange 
R279H_r  GAT TAA AAT TGG ACG GTG GTT CAT TCC TCC GAC 
GCA G 
 
Quickchange 
MI->QR_f  CGT GAG ACG TAC GAG CAG TTG CTG AAG CGC AAA 
GAG TCA CTG GAG 
 
Quickchange 
MI->QR_r  CTC CAG TGA CTC TTT GCG CTT CAG CAA CTG CTC 
GTA CGT CTC ACG 
 
Quickchange 
gammaDEL_PN_f  CAT TCC AAC CCC CCA AAC TAG TCC GTG TAC CCA 
TAG 
 
Quickchange 
gammaDEL_PN_r  CTA TGG GTA CAC GGA CTA GTT TGG GGG GTT GGA 
ATG 
 
Quickchange 
gammaDEL_RG_f  GAG CTT GTG GAG CCC TAG GGA GAA GCT CCG ACA 
CAG 
 
Quickchange 
gammaDEL_RG_r  CTG TGT CGG AGC TTC TCC CTA GGG CTC CAC AAG 
CTC 
 
Quickchange 
gammaDEL_RH_f  GAC GTC TTC TTT AGA CAT TAG AAC CCC CCA AAC 
CAC TCC 
 
Quickchange 
gammaDEL_RH_r  GGA GTG GTT TGG GGG GTT CTA ATG TCT AAA GAA 
GAC GTC 
 
Quickchange 
gammaDEL_TQ_f  GGA GAA GCT CCG ACA CAG TAG GAC GTC TTC TTT 
AGA C 
 
Quickchange 
gammaDEL_TQ_r  GTC TAA AGA AGA CGT CCT ACT GTG TCG GAG CTT 
CTC C 
 
Quickchange 
gamma_PTQS 
>PAQA_f 
CGG GGA GAA GCT CCG GCA CAG GCT GAC GTC TTC 
TTT AGA 
 
Quickchange 
gamma_PTQS 
>PAQA_r 
TCT AAA GAA GAC GTC AGC CTG TGC CGG AGC TTC 
TCC CCG 
 
Quickchange 
Tagamma wo 
Helix_f 
CAT GCA GTA CCT CCC TCA GCA CTG CTT CAG GAA 
TGA GCT TGT G 
 
Quickchange 
Tagamma wo 
Helix_r 
CAC AAG CTC ATT CCT GAA GCA GTG CTG AGG GAG 
GTA CTG CAT 
 
Quickchange 
RT-Osteoc_f  GGG GGG ATG AGA GCC CTC ACA CTC CTC  RT-PCR 
RT-Osteoc_r  TTT TTT GCC GTA GAA GCG CCG ATA GGC  RT-PCR 
RT-Coll_f  TTT TTT GGA CAC AAT GGA TTG CAA GG  RT-PCR 
RT-Coll_r  GGG GGG TAA CCA CTG CTC CAC TCT GG  RT-PCR 
RT-Osteop_f  GGG GGG CAT CTC AGA AGC AGA ATC TCC  RT-PCR 
RT-Osteop_r  TTT TTT CCA TAA ACC ACA CTA TCA CCT  RT-PCR 
RT_VDR_f  TTT TTT CAG TAA CAG GTT GCG ACG GAG  RT-PCR 
RT_VDR_r  TTT TTT GAT GAT TAT AGG TGC GGA TAC  RT-PCR 
RT_p21_f  TTT TTT AGG CGC CAT GTC AGA ACC GGC  RT-PCR 
RT_p21_r  TTT TTT GGA AGG TAG AGC TTG GGC AGG  RT-PCR 
 
  374.14 Vectors 
 
4.14.1 pBH4  
 
The pBH4-Vektor was used for the expression of the ODΔQPSAM-construct. It is 
an expression vector with a T7-Promotor, an ampicillin resitance gene and a N-
terminal His-Tag.  
 
 
 
 
 
 
 
 
 
 
 
Figure 8: pBH4-Vector 
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Figure 8: pBH4-Vector 
 
 
The gene for the expressed ODΔQPSAM construct has been inserted between 
the restriction sites for BamHI and XhoI. For expression E.coli BL21 were used. 
  384.14.2 pcDNA3  
 
The pcDNA3-vector is a vector for expression in mammalian cells. A myc-tag is 
encoded N-terminal to the inserted protein. 
 
  
Figure 9: pcDNA3-Vector [taken from ref. 83] 
 
The genes for the p63 constructs were inserted between the restriction sites XhoI 
and  XbaI. The pcDNA3 constructs, which were not cloned with the 
Oligonucleotides (the FTL->AAA primer listed was used for the ΔNp63α 
construct) listed in 4.13 were cloned by Dr. Wesley McGinn-Straub. 
 
 
 
 
  394.14.3 pGL3 
 
Figure 10: pGL3-Vector [taken from ref. 84] 
The promoters of p21 and bax have been inserted between the restriction sites 
NheI (p21) / SmaI (bax) and XhoI. The pGL3 vector containing the bax promoter 
was cloned by Dr. Horng Der Ou. 
 
4.14.4 pRLCMV 
 
Figure 11: pRLCMV-Vector [taken from ref. 85] 
  405. Methods 
 
5.1 Molecular  biology  methods 
 
5.1.1 Obtaining chromosomal DNA from mammalian cells 
 
For the pGL3 construct containing the p21 promoter sequence the corresponding 
DNA sequence had to be obtained by PCR out of chromosomal DNA [86]. For 
this purpose 5 X 10
4  SAOS2 cells were lyzed in 50 µl Buffer D. The mixture was 
incubated for 55°C for 15 min, vortexed, and incubated again for 15 min at  55°C.  
The final volume was brought to 500 µl with ddH20 and the sample was incubated 
for 5 min at 95°C. 1 µl of this sample was used as template for PCR. 
 
 
5.1.2  Polymerase Chain reaction (PCR) 
 
Defined DNA-fragments can be amplified by using the PCR. In a first step the 
DNA double strand (template) is denaturated, to make the second step possible 
where oligonucleotides as primers can anneal to their complementary sequence 
within the template. It is possible to use chromosomal DNA, plasmid DNA or short 
DNA fragments as a template. After annealing of the primers the 3’-OH ends get 
extended by the thermostable DNA-Polymerase of choice. The Vent Polymerase 
was used, if the template has been a plasmide, the Phusion Polymerase has 
been used, if the template has been chromosomal DNA, according to 
manufacturer’s instructions. The length of the newly synthesized DNA double 
strand depends on the time fort the extension. After the extension time, 
denaturing of the DNA starts again and the new double strands act as templates 
in the new cycle. In this way it is possible to get a huge amount of a defined DNA 
fragment. The used amounts of each component in a standard PCR reaction are 
listed below. 
 
 
 
  41PCR 
50   µl total volume 
  1   µl forward primer [10µM] 
  1   µl reverse primer [10µM] 
  1   µl DNA Polymerase [2 U / µl] 
  1   µl template-DNA (50 ng) 
  1  µl dNTPs [10mM] 
  5   µl 10x DNA-Polymerase Buffer 
 40  µl ddH20 
 
 
 
 
 
 
 
 
 
 
The theoretical annealing temperature of the primers depends on the content of 
Guanine and Cytosine basepairs and the length and can be calculated by the 
following equation. 
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TM  : Melting temperature of the oligonucleotides [°C] 
TA  : Annealing temperature [°C] 
%GC  : GC-content of the oligonucleotides % 
n  : Number of nucleotides within the oligonucleotide  
 
The used standard PCR programme is shown below. All steps can differ in time 
and for the annealing step (below at 62°C) also the temperature can differ. 
  PCR programme: 
 
  °C   sec 
  95    60 
  95    45   -- 
  62    45     | 35x 
  72    60   -- 
 72  300 
    4   ∞ 
 
 
 
 
  42PCR purification and gel extraction were performed using the Qiagen QIAquick 
PCR Purification Kit and QIAquick Gel Extraction Kit according to manufacturer’s 
instructions. 
The PCR-product can be used in different ways i.e. for ligation. 
 
 
5.1.3 Agarose gel electrophoresis 
 
This method was used to separate different DNA-fragments by size. 1% (w/v) 
Agarose were diluted in 1 X TAE-buffer and heated in the microwave until the 
solution becomes clear. At a temperature of approximately 60°C 2 µl of 
ethidiumbromide (98 %) were added to 50 ml agarose solution and the solution 
was put into a gelbox to polymerize. Afterwards the gel was covered with 1 X 
TAE-buffer in a chamber, the DNA + loading buffer was loaded and the voltage 
was set to 100 V for 60 min. The DNA now gets separated because of the 
negative charge and small fragments move faster inside the gel than big ones. 
The DNA bands get visible by treatment with UV-light because of the ethidium 
bromide and the bands corresponding to the right products can be cut out of the 
gel with a scalpel. 
 
 
5.1.4 Digestion of DNA with restriction endonucleases 
 
Restrictionendonucleases are used for specific cutting of dsDNA and normally cut 
at a specific palindromic DNA-sequence. Every digestion was carried out with 
restriction enzymes from New England Biolabs according to the manufacturers 
instruction. 
 
 
5.1.5 Ligation 
 
After PCR amplification of the gene of interest with gene-specific primers 
containing overhanging ends with restriction enzyme recognition sequences, the 
PCR product was purified and digested with the appropriate restriction enzymes.  
  43The vector backbone was also digested with restriction enzymes. Backbone and 
PCR products were separated by agarose gel electrophoresis and extracted from 
the gel with the help of the QIAquick gelextraction kit. PCR product and backbone 
were ligated. Ligations were performed in 20,5 µl, using the T4-DNA-ligase from 
NEB according to the manufacturer’s instructions. The molar ratio of insert to 
vector was 1:1 or 2:1 with a maximum amount of 50ng vector DNA. The ligation 
was performed overnight at 4°C and 10 µl were transformed the next day into 
bacteria. After overnight incubation at 37°C, colonies were picked, and grown in 
6ml liquid culture overnight. The next day, plasmid DNA was purified and 
analyzed by restriction digest for insertion of the PCR product into the vector 
backbone. Positive clones were submitted for sequencing. 
 
 
5.1.6 Mutagenesis 
 
Mutagenesis was carried out with the QuikChange® Site-Directed Mutagenesis 
Kit from Stratagene. A Quickchange (QC) in general works like a normal PCR, 
but within the primers there are some mismatching nucleotides to the 
complementary DNA sequence of the template. Due to this fact the annealing 
becomes more complicated and the primers for this mutagenesis reaction are 
normally longer than non mismatching primers. The PCR reaction itself is very 
similar to the normal PCR-reaction and just has a longer annealing time. And the 
reaction mixture is digested by DpnI after the PCR is completed to get rid of the 
methylated wild type template DNA so only the modified DNA gets transformed 
later on. The used amounts of each component for standard QC are listed below. 
 
Quickchange PCR 
25     µl total volume 
 0,5   µl forward primer [10 µM} 
 0,5   µl reverse primer [10 µM] 
 0,5   µl Pfu Turbo DNA-Polymerase [2.5 U / µl] 
 0,5   µl template-DNA (25 ng) 
 2,5   µl 10x Pfu buffer 
 0,5   µl MgSO4 [100 mM] 
 0,5   µl dNTPs [10 mM] 
19,5  µl ddH20 
 
 
 
 
 
 
 
  44The used standard QC-PCR programme is shown below. All steps can differ in 
time and for the annealing step (below at 62°C) also the temperature can differ 
even more than for a normal PCR (between 50 and 68 °C). 
 
 
QC PCR programme: 
 
  °C min 
  95    2 
  95    1  -- 
  62    2    | 24x (16+1 per mutated nucleotide) 
  72  16  -- 
 72  10 
    4   ∞ 
 
 
 
 
 
 
 
 
After the completion 0,5 µl DpnI [20 U / µl] were added to the reaction and 
incubated for 1 h. Afterwards transformation into E.Coli  DH5α-cells was 
performed. 
 
 
5.1.7 Transformation   
 
For the synthesis of any plasmide DNA 100 µl of competent  E.Coli  DH5α-cells 
[Optical density = 11] were transformed with 1 µg DNA (Mini or Midi preparation) 
or 10 µl Quickchange or ligation reaction mix and incubated for 30 min on ice. 
Then the cells were incubated for 45 s at 42°C (heatshock) and afterwards kept 
on ice for 2 min. If the transformed DNA has been out of a Mini or Midipreparation 
the cells were plated out at this point on agar plated containing an antibiotic 
corresponding to the transformed plasmid. For QC or ligation DNA 100 µl SOCS 
media were added now and the cells were incubated for 30 min at 37°C. Then 
they were centrifuged for 5 min at 5000 g and resuspended in 100 µl LB media. 
The mixture was plated out on agar plates containing an antibiotic. The plates 
were incubated for 10-16 h at 37°C. Colonies on the plates were picked for DNA-
preparation and analysis and grown in 6 ml LB media containing the antibiotic 
corresponding to the transformed plasmid i.e. 1 mg ampicillin per ml media.  
  455.1.8  Isolation of plasmid DNA (Mini-/Midi-Preparation) 
 
For isolation of DNA by Mini preparation 6 ml of an overnight culture of plasmid 
containing bacteria were harvested by centrifugation at 5000 g for 10 min and the 
Mini preparation kit of Macherey Nagel was used according to the manufacturers 
instruction.     
Midi preparation was performed by using the Endotoxin-free Qiagen Kit. All steps 
of the protocol were carried out according to the manufacturers instruction but the 
used volumes of buffers were modified in the following way. 
Resuspension (Step 4) = 4 ml P1 
Lysis (Step 5) = 4 ml P2 
Neutralization (Step 6) = 4 ml P3 
Endotoxin removal (Step 9) = 1 ml ER 
Equilibration (Step 10) = 4 ml QBT 
Washing (Step 12) = 2 X 10 ml QC 
Elution (Step 13) = 5 ml QN 
Precipitation (Step 14) = 3.5 ml isopropanole 
Washing (Step 15) = 2 ml Ethanol (70 %) 
 
 
 
5.1.9 Determination of DNA-concentration 
 
The DNA concentration was determined by measurement at a Nano drop. The 
purity of the DNA was analyzed by use of the measured spectra and the ratio of 
the absorption at 260 and 280 nm. 
 
 
5.1.10 DNA-Sequencing 
 
DNA sequencing was performed by the Research & Development GmbH in 
Oberursel.  Plasmid DNA and primers were submitted at the suggested 
concentration and volume.  
 
  465.1.11 Reverse Transcriptase PCR 
 
Reverse Transcriptase PCR was performed with the Cells-direct RT-PCR Kit 
(Invitrogen) according to the manufacturers instruction. The primers for PCR 
reaction are listed in Table X. 
 
 
5.2 Protein  chemistry 
 
5.2.1 Protein  expression 
 
For the expression of the ODΔQPSAM construct the pBH4 vector was used. 
E.coli BL21 (DE3 rare) were transformed with 1 µl of a Mini DNA preparation and 
plated out on an agar plate with ampicillin and chloramphenicol antibiotics (100 
µg / ml]. A colony was picked for a 6 ml overnight preculture of LB-Media with the 
antibiotics [100 µg / ml]. This culture was centrifuged and resuspended in LB 
Media and put into 500 ml of expression media (2XYT) containing ampicillin [100 
µg / ml]. Afterwards the culture was grown at 37°C and 180 rpm to an OD600 of 
0,8 and induced with 500 µl of 1M IPTG. After  incubation over night at 22°C and 
180 rpm the culture was centrifuged at 5000 g for 10 min. The cell pellet was 
resuspended in 20 ml cell lysis buffer (4°C). The cells were incubated with 
lyzozyme for 15 min on ice and were  lysed by sonification (3 x 1 min). Then the 
lysate was centrifuged at 50.000 g and the supernatant was kept for purification.  
 
 
5.2.2  Purification by Ni-NTA 
 
The supernatant was filtered and loaded on a Ni-NTA FF column connected to an 
Äkta system. The Histidine side chains (His-tag) bind to the Nickel resin and 
proteins were purified by washing with buffer containing an Imidazole 
concentration up to 100 mM. The elution buffer for the protein contains 250 mM 
Imidazole. The collected fractions were analyzed by SDS-PAGE and dialyzed to 
get rid of the Imidazole.  
  475.2.3 Size exclusion chromatography (Gelfiltration) 
 
Proteins can be separated by size using a gelfiltration column. Also different 
oligomeric states can be analyzed by gelfiltration. Big molecules move faster to 
the column than small ones. By calibration with molecules of known sizes even 
the mass of a molecule can be determined approximately or the oligomeric state. 
For analysis of the oligomeric state of a wt ODΔQSAM and a mutant ODΔQPSAM 
construct a Superdex 75 column was used, which had been equilibrated before 
with two column volumes lysis buffer. The protein samples had a volume of 5 ml, 
the flow rate was 1 ml/min. The eluate of the peak fractions was analyzed by 
SDS-PAGE.  
 
 
5.2.4 Determination of protein concentration 
 
The protein concentration was determined by measurement at a Nano drop. The 
purity of the protein was analyzed by use of the measured spectra. 
 
 
 
5.3 Analytical  methods 
 
5.3.1 SDS-Polyacrylamidgelelectrophoresis (SDS-PAGE) 
 
Proteins are separated by size by SDS-Polyacrylamidgelelectrophoresis. The 
proteins get denaturated and negatively charged because of the detergent 
Sodiumdodecylsulfat (SDS). Approximately one SDS-molecule binds to 2 amino 
acids. The protein samples for analysis of the protein expression were analyzed 
on 12% SDS gels at 200 V for 60 min, stained with Coomasiee, destained and 
scanned. 
For samples obtained from mammalian cells SDS-polyacrylamid-
gelelectrophoresis was performed using the NuPAGE Novex Gel system from 
Invitrogen with purchased NuPAGE 4-12% BisTris gels. Protein samples were 
  48mixed with 20 µl 4X sample buffer containing 20 % β-ME, incubated for 5 min at 
95°C, and centrifuged for 1 min at 13000 g. The Gels were run in 1x MOPS buffer 
(Invitrogen) at 200 V for 50 min.  
 
 
5.3.2 Western Blot (WB) 
 
Proteins were transferred from the gel to a Polyvinylidene fluoride (PVDF) 
membrane using a wet-blot method from Invitrogen according to the 
manufactures instruction. Proteins were transferred at 30V for 90 min at room 
temperature  (transfer buffer 4°C at beginning).  After the transfer the membrane 
was blocked in TBST containing 5% milk for 30 min. After that, the membrane 
was incubated with TBST  containing 5% milk and the primary antibody at the 
concentration suggested by the manufacturer overnight at 4°C.  The membrane 
was washed 3 times for 10 min with 50 ml TBST and incubated in TBST 
containing 5% milk and the secondary antibody at the concentration suggested by 
the manufacturer for 1h at room temperature.  The membrane was washed 3 
times for 10 min with 50 ml TBST  and then the incubated 1 min in 6 ml ECL1 
followed by 1 min ECL1 + 6 ml ECL2 for detection of chemiluminescence. The 
membrane was exposed in a Ilumimeter and the obtained data was analyzed. 
The strength of the signals was analyzed quantitatively using the BioDocAnalyze 
2.0 software.  
 
 
 
5.4.  Cell biology methods 
 
5.4.1 Cell culture 
 
SAOS2 cells, obtained from the ATCC, were cultured in Dulbecco’s modified 
Eagle’s media (DMEM) with 10% fetale bovine serum, 1 % penicillin-streptomycin 
[100 U / ml] and 1 % L-Glutamine [200 mM], at 37°C under an atmosphere of 5% 
CO2. For experiments 96 well plates were used, the cell concentration per ml was 
  497 X 10
4 / ml cell, if the experiment was performed the next day after seeding, 
otherwise 5 X 10
4 / ml cells for experiments 2 days after seeding. 
 
 
5.4.2 Immunofluorescence 
 
For immunofluorescence, SAOS2 cells were plated on 12mm coverslips and 
grown overnight.  24 h after transfection the media was aspirated and cells were 
fixed with 3% formaldehyde in PBS for 8 min at room temperature. Then, cells 
were washed 4 X with PBST (PBS/0.1% Triton-X100) and blocked with 3% milk in 
PBST for 30 min at room temperature.  Cells were incubated with 100 µl 3 % milk 
in PBST containing the Cy3 c-myc-specific antibody 9E10 (light sensitive) at the 
concentration suggested by the manufacturer for 1h at room temperature, 
followed by 3 washing steps with PBST and incubation with secondary antibody 
for 30 min at room temperature.  After 3 additional washing steps the DNA of the 
cells was stained with fluorochrome Hoechst 33278 diluted in PBST to 1μg/ml for 
1 min. The cells were washed again 2 times with PBST and coverslips were 
mounted onto microscope slides using small amounts of mounting media and 
sealed with nail polish. Pictures were taken on an Zeiss Axiovert 200 microscope 
connected with a Zeiss Axiocam MrM. Two different filters were used, one for the 
Hoechst Stain signal (DAPI) and one for the Cy3 signal (Cy3). 
 
 
5.4.3 Microscopy   
 
Cells were observed during cultivation and pre-experimental at the light 
microscope Axiovert 40 CFL. 
 
 
 
 
 
 
  505.4.4 Transfection 
 
The transactivation experiments were 
performed in SAOS-2 cells using the 
Promega Dual-Glo
TM Luciferase reporter 
assay.  The used promoter pGL3 vector was 
created before and carried either a single 
copy of the p21 or the bax promoter. Cells 
were transfected with 133 ng DNA per 
plasmid, using the Effectene system from 
Qiagen [Fig. 12]. Transfections were carried 
out in 96 well plates according to the protocol 
[appendix], cells were grown for 24 hours 
and assayed for Renilla and Firefly luciferase 
activities or western blot. In the titration 
assays, the concentration of TAp63γ was 
kept constant at 62 ng per assay and the 
amount of  ΔNp63α  plasmid  was  varied from  Figure  12:  Effectene  Transfection    
a ratio of 1:5 to 5:1. The total amount  of  DNA    [taken from ref. 87]. 
transfected was kept constant with pCDNA3.1  Plasmid DNA gets condensed by         
vector. Experiments were performed  as  three    Enhancer molecules and afterwards 
independent    experiments    each    in       micelles  are  formed  via  Effectene. The 
triplicate.                  formed complexes get into the cells by 
            endocytosis. 
 
 
5.4.5 Transactivation  assays 
 
For the transactivation experiments the Promega Dual-Glo
TM Luciferase reporter 
assay was used according to the manufacturers instruction. The scheme how it 
works is shown in Fig. 13. The transcriptional activity obtained by these 
experiments was the relative activity (of the analyzed constructs to TAp63γ). 
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Figure 13: Luminescence Reporter Assays Overview [taken from ref. 84, modified]. In blue 
the starting point for the carried out experiments is shown. As a transcription factor p63 binds to 
the promoter sequence in the cotransfected pGL3 vector. The more transcriptional activity the p63 
construct has, the more firefly luciferase gets transcripted and the more signal is measured. 
Background transcriptional activity is obtained by measurement of a second signal obtained by 
the constitutive transcription of the renilla luciferase gene in the pRLCMV vector.  
 
The vector containing the gene of the protein was a pcDNA3 vector. A pGL3 
vector with either a p21 or bax promoter in front of the firefly luciferase gene was 
used a reporter construct and the background vector has been the pRLCMV 
vector with a common promoter in front of the renilla luciferase gene.  
 
 
5.4.6 Harvesting mammalian cells for WB analysis 
 
The cells, which were transfected in the same way as for transactivation assays, 
were harvested using Accutase (PAA) and centrifuged at 750 g at 4°C. The Cells 
were lysed using the mammalian protein extraction reagent mixture (Pierce). The 
supernatant was removed and 23 µl of the reagent was used for lysis of the pellet 
with 5 min incubation. After that the procedure has been according to 5.3.1. 
 
 
  526. Results 
 
6.1. Functional analysis of the C-terminus of TAp63α 
 
6.1.1 Mutational analysis of the TID 
A mutational analysis of the C-terminus of TAp63α was carried out. The 
transcriptional activity on the p21 promoter of several constructs with multiple 
alanine mutations was analyzed by luciferase assays. The results are shown in 
Fig. 14. 
 
 
Figure 14: Transcriptional activities on the p21 promoter of different TAp63α constructs 
transfected into SAOS2 cells. The activities are shown relative to the wild type of TAp63γ 
(green), the wt of TAp63α is shown in blue. The activities were measured by luciferase 
transactivation assays. The indicated amino acids were mutated to alanine [taken from ref. 53].  
 
Most of the constructs with a significantly increased transcriptional activity 
compared to the wild type TAp63α (TAp63α.wt) in blue are in the region starting 
with the amino acid F605 and ending with R616. In this region also lies a stretch 
of conserved amino acids shown in Fig. 6. The other constructs showing 
significantly increased transcriptional activity are SVG (TAp63α.
SVG>AAA) and QRI 
(TAp63α.
QRI>AAA). The increased activity of QRI is a consequence of affected 
sumoylation and has been demonstrated before [15, 53]. In the presented 
  53diagram the transcriptional activities are not normalized to the intracellular protein 
concentration of each construct. To distinguish between protein concentration 
and other effects, western blot analysis was carried out for each analyzed 
construct to correlate (normalize) the transcriptional activities to the protein 
concentrations. The corresponding Western Blots are shown in Fig. 15. 
 
 
Figure 15: Western Blots of the analyzed TAp63α constructs and TAp63γ. The signal for the 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) has been used as loading control to 
compare the p63 signals to each other [taken from ref. 53]. 
 
It can be observed (with of SVG and QRI) that the constructs with increased 
transcriptional activity show low concentrations inside the cells. Normalization of 
the transcriptional activities by this western blot data leads to the normalized 
transcriptional activities outlined in Fig. 16. 
 
 
Figure 16: Transcriptional activities of the TAp63α constructs relative to the wt of TAp63γ 
and normalized to intracellular protein concentration [taken from ref. 53]. 
 
  54It can be seen, that after consideration of the intracellular protein concentrations 
the constructs with mutated amino acids in the region between F605 and R616 
show a significantly higher intrinsic transcriptional activity. Compared to the other 
regions some amino acids in this region are also highly conserved [Fig. 6]. The 
other constructs appearing more active in the relative transcriptional activity 
measurements [Fig. 14] show transcriptional activity levels similar to the wt after 
normalization. To investigate, if the effect of higher transcriptional activity in the 
identified stretch of amino acids is independent from regulation mechanisms, like 
sumoylation, additional experiments were carried out as described below. 
 
 
6.1.2 Effects of a mutated sumoylation site in TAp63α 
 
Pulldown experiments done previously had reported that the last 25 amino acids, 
including the sumoylation site are not important for binding of the TA-domain [15]. 
To further elucidate this sumoylation-independent way of regulating TAp63α and 
to confirm the sumoylation-independence of the previously identified region the 
consequences of an affected sumoylation site was investigated in different ways. 
In one study the acceptor lysine K637 of TAp63α was mutated into leucine 
(TAp63α.K). In the second study the three amino acids in front of the acceptor 
lysine have been mutated into alanines (QRI). The consequences of these 
mutations at the relative and normalized transcriptional activity level on the p21 
promoter are shown in Fig. 17. 
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Figure 17: Consequences of an affected sumoylation site in TAp63α compared to 
TAp63α.wt (dark )blue and TAp63γ.wt (green). The first series shows the relative transcriptional 
activity measured and the second the normalized transcriptional activity [taken from ref. 53]. 
 
Figure 17 shows that both mutations have the same effect on the relative and 
normalized transcriptional activity of the protein. The higher relative activity 
compared to the wild type is just due to a higher protein concentration. After 
normalization the transcriptional activities for both constructs are the same as for 
the wild type. In the case of TAp63α.wt the mutation of the sumoylation site leads 
to higher transcriptional activity due to higher intracellular protein concentrations. 
 
 
6.1.3 Independence of intrinsic and sumoylation dependent activity 
 
To test the effect of higher intracellular protein concentrations and to proof that 
the two observed implications on transcriptional activity are independent from 
each other an additional mutational analysis with other constructs was carried 
out. In these construct an additional mutation was introduced to the TAp63α 
constructs shown in Fig. 7. Added to the mutation in the TI-domain also the 
acceptor lysine of the sumoylation site (K637) was mutated to leucine. The 
relative transcriptional activity on the p21 promoter for all of these constructs was 
  56measured and the resulting values are shown in Fig. 18. 
 
 
Figure 18: Effects of an affected sumoylation site on the TAp63α constructs. In blue TAp63α 
with the single mutation K637L, in green TAp63γ.wt [taken from ref. 53]. 
 
It can be seen, that those constructs which showed the highest transcriptional 
activity in the previous experiments increase even more in their relative 
transcriptional activity with the additional mutation of K637L. The other mutants 
are as or less transcriptionally active than the construct with the single mutation 
K637L. When compared to the results of the experiment shown in Fig. 14, the 
overall increase in transcriptional activity seems to be just an effect of higher 
protein concentration and not of an altered intrinsic transcriptional activity. To test 
this hypothesis western blots for all constructs were carried out in the same 
manner as before. The western blots are shown in Fig. 19. 
 
 
Figure 19: Western Blots of the TAp63α.K constructs and TAp63γ.wt, which have been 
analyzed in the transactivation assays [taken from ref. 53]. 
 
The protein concentration in general is increased when compared to the data in 
  57Fig. 15. Again the most active constructs show relatively low intracellular protein 
concentrations. The change in protein level for each construct is shown in Fig 20. 
  
 
Figure 20: Fold change in protein concentration due to an additionally mutated 
sumoylation site for each analyzed TI-mutant construct of TAp63α. Constructs, where only 
the sumoylation site is mutated are indicated in blue (K637L) and red (QRI) [taken from ref. 53].    
 
Most constructs show elevated intracellular protein concentrations after mutation 
of the acceptor lysine K637 into leucine. The fold change for the construct 
carrying only this single mutation (blue) is similar to the construct QRI (red), 
where the receptor lysine remains intact. The normalized transcriptional activities 
after including the protein concentrations are shown in Fig 21. 
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Figure 21: Transcriptional activities of TAp63α constructs with an additional mutation at 
the sumoylation site (.K). Activities are relative to TAp63γ.wt and normalized to protein 
concentrations. The single mutation mutant is indicated in blue and TAp63γ in green [taken from 
ref. 53]. 
 
The normalized activities of the mutants show a similar pattern as the normalized 
activities of the mutants without the additional mutation K637L. Therefore there 
are two independent regulatory functions located at the C-terminus of TAp63α. 
One of them is based on sumoylation and influences the intracellular protein 
concentration. The other one seems to be involved in binding and masking of the 
TA-domain and the important residues are located in the highly conserved region 
beginning with F605. 
 
 
6.1.4 High transcriptional activity is connected to low intracellular protein 
levels 
 
It is obvious that the TAp63α-constructs which carry mutations between F605 and 
R616 show high transcriptional activity while they have a low intracellular 
concentration. This is similar to TAp63γ. To elucidate if this is a consequence of 
the increased transcriptional activity or other reasons i.e. degradation of the 
protein further experiments were carried out. An additional mutation in the DNA-
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TAp63α.FTL.K (FTL.K), which leads to complete transcriptional inactivity of these 
constructs. The intracellular protein concentration of the transcriptionally active 
and the transcriptionally inactive constructs was analyzed by western blots. The 
results are shown in Fig. 22.  
 
 
Figure 22: Western Blots of the transcriptionally active TAp63α-constructs and the 
respective DNA-binding domain mutants and TAp63α wt [taken from ref. 53]. 
 
Figure 22 clearly shows that the transcriptionally inactive constructs have a higher 
intracellular concentration than the active ones. Therefore there seems to be an 
additional regulation step for transcriptionally active TAp63α-forms which acts at 
the protein level. Such a control mechanism might be essential for keeping the 
cellular environment stable. 
The concentration of FTL.DBD.K is increased in comparison to FTL.DBD also in 
this case with the additional mutation K637L. The impacts caused by mutation of 
the sumoylation site (FTL.K.DBD) are similar to the wt even though the amino 
acids FTL are mutated to alanine.  
 
 
6.1.5 Transcriptional activity of the TID-mutants on the bax promoter 
 
So far the data for transcriptional activity have been obtained on the p21 
promoter. To test if there is any promoter specific effect the transcriptional activity 
for the analyzed constructs containing mutations in TI and / or  sumoylation site 
were carried out in the same way as on the p21 promoter on the bax promoter. 
The corresponding data is shown in Fig. 23. 
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Figure 23. Relative transcriptional activity for the TAp63α constructs on the bax promoter. 
Grey bars show the constructs with the mutations in the TI domain. Black bars show the 
constructs with the additional mutation K637L. The wt of TAp63α is indicated in light blue, the 
corresponding sumoylation mutant in dark blue. TAp63γ is indicated in green [taken from ref. 53]. 
 
As on the p21 promoter the constructs with mutations in the stretch between 
F605 and R616 are the most active ones, suggesting that the same amino acids 
are crucial for the inhibitory function. Surprisingly the additional K637L mutation 
leads to no additional increase in the transcriptional activity in most of the 
constructs while in the wild type this single mutations leads to an increase in 
transcriptional activity (as on the p21 promoter). 
To test if the effect of sumoylation is promoter-dependent for active TAp63α 
forms western blots were performed to obtain the intracellular concentration 
levels. This was carried out for TAp63α.wt, TAp63γ.wt, TAp63α.FTL and the 
corresponding constructs of TAp63α with the additional K637L mutation. The 
transcriptional activities and the corresponding western blots are shown in Fig. 
24. 
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Figure 24: Relative and normalized transcriptional activities and protein levels for the 
TAp63α constructs and TAp63γ on the bax promoter [taken from ref. 53].  
 
The result for TAp63α and TAp63α.K is similar to that obtained on the p21 
promoter. In contrast to that TAp63α.FTL and TAp63α.FTL.K show the same 
relative transcriptional activity and intracellular concentration on the bax promoter. 
The resulting normalized activity per protein on the bax promoter is the same in 
case of FTL and FTL.K as on the p21 promoter. The identified stretch of amino 
acids seems to be important for the intrinsic regulation of the protein in both 
cases and therefore seems to be promoter independent, while sumoylation 
seems to depend on the promoter to which the protein binds. 
  626.1.6 Subcellular localization of inactive and active TAp63α constructs 
 
To exclude the possibility that an altered subcellular localization might be the 
reason for changes of transcriptional activity, immunofluorescence data was 
carried out. The results are shown in Fig. 25. 
 
 
Figure 25: Immunofluorescence data for constructs of TAp63α and TAp63γ.wt transfected 
in SAOS2 cells. In red the signal of the Cy3-coupled anti-myc antibody is shown, in blue the 
DAPI stain of the nucleus [taken from ref. 53]. 
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TAp63 constructs. Therefore the differences in transcriptional activity are not 
caused by an altered subcellular localization of TAp63. 
 
 
6.1.7 Effects of a deleted QP domain 
 
All presented results of TAp63α were obtained for the full-length protein. To 
investigate if the QP domain between the OD and SAM has an influence either on 
the identified region (FTL) or the sumoylation the transcriptional activity of several 
constructs without the QP domain was measured [Fig. 26]. 
  
 
Figure 26: Transcriptional activity of several TAp63α constructs lacking the QP domain 
relative to TAp63γ in SAOS-2 cells. In blue TAp63α wt, in green TAp63γ wt [taken from ref. 53]. 
 
Figure 26 shows that the previously observed effects on transcriptional activity 
are similar in constructs without the QP domain. Therefore the QP domain seems 
to have no influence on the previously described effects (Sumoylation, FTL). 
 
 
 
  646.2. Implications on ΔNp63α 
 
6.2.1 Impacts of mutations in the TID on the inhibitory potential of ΔNp63α 
 
The experiments presented in 6.1 have shown effects of AA F605 to R616 on the 
transcriptional activity of TAp63α. To test if these results also influence ΔNp63α, 
which also has a TI-domain, additional experiments were carried out. The 
TAp63α construct FTL showed the highest transcriptional activity of all TAp63α 
constructs. Therefore an analogue mutation was carried out in ΔNp63α. Other 
constructs were created with additional mutations in the DBD for both 
ΔNp63α.FTL and ΔNp63α.wt. The ΔNp63α constructs were tested for 
transcriptional activity on the p21 promoter. The results are  shown in Fig. 27. 
 
 
Figure 27: Transcriptional activity of TAp63α, TAp63γ and ΔNp63α constructs on the p21 
promoter relative to TAp63γ in SAOS-2 cells. In blue TAp63α wt, in green TAp63γ wt [taken 
from ref. 53]. 
 
As expected the ΔNp63α constructs both show low transcriptional activity on the 
p21 promoter. Therefore this mutation has no effect on the transcriptional activity 
of ΔNp63α on the p21 promoter. To test, if the mutation has any effect on the 
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experiment. Constant amounts of plasmid-DNA encoding TAp63γ wt and 
increasing amounts of plasmid-DNA encoding various ΔNp63α constructs had 
been co-transfected. The results on the p21 promoter are shown in Fig. 28. 
 
 
Figure 28: Relative transcriptional activity of TAp63γ transfected with increasing amounts 
of different ΔNp63α constructs and respective western blots [taken from ref. 53]. Ratios 
between transfected TAp63γ and ΔNp63α plasmid DNA are shown on the x-axis and above the 
protein levels. 
 
The shown western blots of the three highest plasmid concentrations of the 
ΔNp63α constructs show increasing protein concentrations with each titration 
step. For nomalization of the transcriptional activities only the data points for the 
three highest plasmid concentrations of ΔNp63α were used. This data is shown in 
Fig. 29. 
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Figure 29: Normalized transcriptional activity of TAp63γ cotransfected with increasing 
amounts of different ΔNp63α [taken from ref. 53].  
 
ΔNp63α behaves strongly dominant negative towards TAp63γ. The net 
transcriptional activity decreases rapidly with increasing amounts of ΔNp63α. 
ΔNp63α.FTL and ΔNp63α.DBD are less but still inhibiting while ΔNp63α.FTL.DBD 
is a weak inhibitor. The relatively high inhibitory potential of ΔNp63α.FTL seems 
to be due to the higher binding affinity to the promoter. This might be due to an 
indirect inhibition based on promoter squelching and independent of the C-
terminal inhibition via the TA-TI-interaction. The two opposing effects compensate 
each other and the overall inhibitory potential of ΔNp63α.FTL seems to be similar 
to that of the wild type. But the inhibition caused by the C-terminus is significantly  
reduced which can be seen by comparison of ΔNp63α.DBD and 
ΔNp63α.FTL.DBD. The weak inhibitory potential of ΔNp63α.FTL.DBD shows that 
it only inhibits by forming tetrameres via the oligomerization domain. The overall 
activity in the case of ΔNp63α.FTL.DBD is 50%, assuming that at high protein 
levels of the ΔN forms of p63 most of the tetramers should consist of mixed 
tetrameres in which the cotranslationally  formed dimers are the basic unit. This 
point will be elucidated in 6.3. 
  676.2.2. ΔNp63α is able to prevent the transcription of certain genes 
 
A higher affinity to a promoter is a mechanism how ΔNp63α might be capable of 
shutting down genes by blocking the binding site for other transcription factors. 
Experiments with several p63-isoforms were carried out by Reverse 
Transcriptase-PCR in SAOS2 cells to elucidate if there is any difference in the 
mRNA level of the investigated genes, which are important for osteogenesis [Fig. 
30]. Those cells were derived from an osteosarcoma cell line and should 
therefore be suitable for these differentiation experiments. 
 
 
Figure 30: DNA-levels of several genes (VDR: Vitamin D receptor) obtained by RT-PCR 
corresponding to the levels of mRNA of these genes inside transfected SAOS2 cells. P21 
as a target of p63 is the control. 
 
There is a difference in the mRNA level between those cells transfected with 
ΔNp63α and the others. The Vitamin D receptor (VDR) plays a crucial role for 
transcription of the other involved genes, therefore ΔNp63α seems to block the 
promoter of VDR and maybe the other genes important for osteogenesis. But the 
observed result could also be a sequential effect and the VDR normally induces 
these genes which show decreased mRNA level. The mRNA level of Osteocalcin 
is also decreased while the mRNA level of p21 seems to be the same. Therefore 
the DNA-binding affinity of ΔNp63α seems to be not sufficient to block the 
promoter of this gene efficiently. For all genes involved in Osteogenesis the level 
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data supports the idea of ΔNp63α inhibiting other factors important for 
transcription like VDR, maybe by preventing their transcription. 
 
 
 
6.3. Analysis of TAp63γ 
 
6.3.1 Impact of oligomerization state on transcriptional activity 
 
The data shown before suggests that a mixed tetramere of ΔNp63α.FTL.DBD and  
TAp63γ might act like a dimer of TAp63γ. Further validation of this hypothesis is 
delivered by transcriptional activity data of the TAp63γ-constructs shown in Fig. 
31.  
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Figure 31: Relative and normalized transcriptional activity of TAp63α.wt (blue) and 
TAp63γ.D (M374Q, I378R) to TAp63γ.wt (green) in SAOS-2 cells [taken from ref. 53]. 
 
To test if the oligomeric state of the protein is a dimer instead of a tetramere two 
  70p63 constructs containing of the oligomerization domain and the SAM-domain 
(ODΔQPSAM) were expressed recombinantly in E.coli and analyzed by 
gelfiltration, one of them with the mutations M374Q and I378R in the 
tetramerization interface. The gelfiltration data is shown in Fig. 32. 
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Figure 32. Elution profile of ODΔQPSAM wild type (blue, 56 ml)) and the construct with the 
mutations in the tetramerization interface (purple, 73 ml) (M374Q, I378R) on a Superdex
TM 
200 Highload 16/60 column. 
 
The observed volumes correspond to the molecular weight of either tetrameres or 
dimers. An equilibrium between tetrameres and dimers can be observed in both 
cases, but the equilibrium is shifted significantly with introduction of the dimer 
mutations (M374Q, I378R) towards the dimeric state of the protein. Nonetheless 
only a qualitative measurement was carried out and no quantitative assay. The 
mutations in the tetramerization interface therefore have effects on the 
oligomerization state in the truncated p63-construct, assuming similar effects in 
the full length protein. 
 
 
6.3.2 Deletion study of the C-terminus of TAp63γ 
 
The experiments and results described in the analysis of the TI-domain [Fig. 16, 
17] show that there are regulatory elements at the C-terminus of the p63α 
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assigned role of biological relevance for TAp63γ described so far, the question 
arises if this most active isoform of p63 is controlled in a similar manner like the 
α-isoforms or if it is controlled similar to p53 to which it shares high structural 
similarity. Because of the lack of previous data on important regions, in contrast 
to TAp63α, a deletion and no mutational analysis was carried out in the beginning 
on TAp63γ. For this purpose several constructs were created and tested for 
transcriptional activity in SAOS2 cells. The corresponding data is shown in Fig. 
33. 
 
 
Figure 33. Relative transcriptional activities of TAp63γ deletion constructs to the wt (green) 
in SAOS-2 cells. The murine gene sequence is indicated below the activity data. The red lines 
indicate at which amino acid the STOP-codon was introduced in the construct. 
 
The results show that the transcriptional activity of the protein does not change 
dramatically until the deleted number of amino acids is about twenty (TQ_STOP). 
The deletion of more amino acids (RG_STOP) has no additional negative effect, 
only after additional deletion of twelve more amino acids (SA_STOP) the 
transcriptional activity returns to wild type levels. In the region is one serine 
(S428) and threonine (T426). In an additional experiment those residues were 
mutated to alanines (PAQA) and the transcriptional activity was measured. This 
  72data is shown in Fig. 34. 
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Figure 34. Transcriptional activities of an alanine mutant of TAp63γ (PAQA) and TAp63γ 
deletion constructs relative to the wt (green) in SAOS-2 cells.   
 
It can be seen that the transcriptional activity of the double alanine mutant is 
nearly at the same level as of the construct RG_STOP which lacks both amino 
acids. Therefore these amino acids might be important for transcriptional activity 
of the protein. Since both amino acids might get modified post-translational the 
probability for phosphorylation was elucidated.  
 
 
6.3.3 Phosphorylation predication 
 
To investigate the possibility of the identified amino acids of getting 
phosphorylated a phosphorylation predication was carried out [Fig. 35].  
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Figure 35. Phosphorylation prediction of murine TAp63γ. The threonine mutated in the alanine 
mutant shown before is indicated by an arrow. The height of the bars stands for the 
phosphorylation potential of  the possible phosphorylation sites in the whole protein [taken from 
ref. 88]. 
 
The phosphorylation prediction shows that one of the identified amino acids might 
get phosphorylated. The phosphorylation potential for the T426 is above 0.5, what 
might mean that phosphorylation occurs at this site. 
 
 
 
7. Discussion 
 
7.1 Functional analysis of the C-terminus of TAp63α 
 
Due to the biological relevance of the transcription factor p63, which is involved in 
key decision processes during ectodermal development, maintenance of mature 
skin and in genotoxic stressed oocytes, its regulation is of outstanding biological 
significance. 
In contrast to p53, which is mainly regulated by the interaction with MDM2 the 
regulation of p63 is more complex due to the expression of at least six different 
isoforms. Two of these isoforms have an extended (full-length) C-terminus 
comprising two independent regulatory elements, which contribute to the auto-
inhibition of TAp63α and the inhibitory effects of ΔNp63α. 
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amino acids which modulates the transcriptional activity if mutated into alanine. 
The pattern of the transactivation activity [Fig. 14] obtained by luciferase assays 
identifies a region with increased transcriptional activity when mutated within the 
TID beginning with F605. Increasing transcriptional activity can also be observed 
if the sumoylation site is affected. This effect of a mutated sumoylation site will be 
pointed out later in this discussion. 
The transcriptional activities of all measured constructs were normalized by 
measuring the intracellular concentration of the protein which was determined by 
western blot [Fig. 15]. This was done to exclude the possibility that the higher 
transcriptional activity is just because of concentration effects and not because of 
intrinsic effects. Earlier investigations had revealed that the most transcriptionally 
active isoform TAp63γ shows a significantly reduced intracellular concentration 
compared to transcriptionally impaired mutants [89]. In western blots the more 
active constructs of TAp63α are less concentrated than those with lower 
transcriptional activity or TAp63α.wt, leading to an even more increased 
normalized activity of these constructs relative to the others and the wild type 
[Fig. 16]. 
The presented results show that transcriptional activity of TAp63α seems to be 
inhibited via a stretch of amino acids in the Transactivation inhibitory domain. The 
identified region seems to be important for regulation of TAp63α by binding to 
and masking the TA-domain. Pulldown experiments showed, that this region is 
crucial for binding the TA-domain in vitro [53]. This might occur by a 
conformational change. 
A point mutation in the identified amino acid stretch has not been reported to 
date, but patients with AEC syndrome carry mutations in the TI domain just N-
terminal to this stretch (R598L, D601V) [90].  Also the biological impact for these 
findings is provided by the recent discovery that TAp63α plays a major role in 
protecting the female germ line [32]. The carried out biochemical experiments 
during this thesis and the finding that ionizing radiation leads to activation of 
TAp63α via phosphorylation and the phosphorylation of TAp63α is coupled to cell 
death of oocytes correlate with each other. Therefore it is most likely that some 
post-translational modification is taking place in this region (FTL) if the inhibition 
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threonines (within FTL) and one highly conserved serine (within TIS) within this 
important stretch, therefore phosphorylation could be a possible mechanism for 
activation of the protein. This leads to the assumption that TAp63α is kept in a 
transcriptionally inhibited conformation with the help of the TI domain. Maybe also 
the oligomerization domain is involved and the oligomeric state is affected by the 
TA-TI interaction, but this has to be elucidated. The identified short stretch of 
amino acids might be essential for keeping the protein in a closed conformation 
and therefore inhibiting its transcriptional activity. This might be due to direct 
binding to one or more domains of p63. Experiments carried out before had 
shown direct interaction between the bacterially expressed TA and the TI 
domains of p63 [15]. Together with the finding that phosphorylation is essential 
for activation of TAp63α in Oocytes this might implicate that several functions of 
the protein are blocked by forming a closed conformation with several other 
domain-domain interactions. Unfortunately a  mutation of T606 to glutamate as a 
phosphorylation mimic does not lead to a significant increase in transcriptional 
activity of TAp63α in SAOS2 cells. This could either mean that this mutation is 
not a good mimetic of phosphorylation in terms of breaking all important contacts, 
or the activation mechanism is more complex and additional modifications are 
needed. 
In the case of p53 several phosphorylations occur during activation of the protein 
[43,44,49,50]. Unfortunately, a kinase which phosphorylates amino acids in this 
stretch of the TID (FTL) of p63 has not been identified to this point. 
The surprising absence of missense mutations in this region of the TID could be 
explained in several ways. Primary a missense mutation could have a lethal 
effect. Due to the gene structure of p63 all α-isoforms in nearly every cell will be 
affected if such a mutation would occur in an early stage of the organism, leading 
most likely to death. Especially possible implications on the ΔNp63α isoform 
might have consequences for the development. Hypothetically a mutation in 
Oocytes leading to an active form of TAp63α would lead to infertility, so this 
mutation is eliminated from the gene pool. Another possibility for the absence of 
observed mutations in the core of the TID is that a syndrome would only arise in 
case of dominant negative or gain of functions effects. If only one allele is 
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lack of a phenotype in heterozygous knock-out mice for p63 [27]. Haploid 
insufficiency only has consequences in rare cases of heterozygous deletions of 
the p63 gene in human patients [34]. Therefore expression from the second, non-
mutated allele seems to be sufficient to compensate possible effects of the 
mutated allele during development and maintenance of epithelial tissue. 
An increased transcriptional activity for TAp63α can also be observed if the 
sumoylation site is affected. This seems to be another way of regulating 
TAp63α via its C-terminus. The mutation of I636 or the acceptor lysine K637 in 
TAp63α leads to an increase in transcriptional activity. Nearly all constructs 
where the acceptor lysine K637 is mutated into leucine show increased 
transcriptional activity [Fig. 18]. Analysis by Western blot reveals, that this is the 
consequence of an increased protein level [Fig. 19]. 
Alanine mutations in the active region again show a low intracellular 
concentration relative to the others in this experiments even though the protein 
concentration increased due to the mutation of the sumoylation site. Overall, for 
most constructs the additional mutation at the sumoylation site leads to an 
increased protein concentration [Fig. 20]. This corresponds to the overall 
increased transcriptional activity. So the increased transcriptional activity of the 
constructs containing the K637L mutation is just due to concentration effects what 
can be seen after normalization [Fig. 21]. The normalized activities show a very 
similar pattern to those experiments carried out with the constructs containing an 
intact sumoylation site [Fig. 16]. Sumoylation therefore seems not to alter the 
intrinsic activity of p63 itself, but changes its intracellular concentration leading to 
a shifted transcription rate of the target genes. 
Accordingly sumoylation might constitute another control mechanism independent 
from the other proposed control mechanism. Nevertheless the biological 
relevance of sumoylation still has to be confirmed, possibly by investigating the 
sumoylation state of p63 in arrested oocytes. 
Concerning the importance of sumoylation, there have also been reports about 
nonsense mutations in patients with SHFM4 syndrome, where protein forms exist 
that are only truncated by a few amino acids [91]. These mutations seem to affect 
only the sumoylation site leaving the rest of the TID and its interactions intact. 
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phenotype of these mutations. The removal or destruction of the sumoylation site 
is enough to lead to the SHFM4 syndrome [34,55]. In other cases of the SHFM4 
syndrome the mutations occur in the transactivation and the DNA binding domain 
[92]. Two of the reported mutations in the DNA binding domain affect lysines 
involved in regulation of the intracellular protein level by ubiquitination of these 
residues by Itch [93]. Accordingly, for the SHFM4 syndrome there might be a link 
to impaired degradation of ΔNp63α. 
ΔNp63α becomes sumoylated in several different cell lines (HaCaT human 
keratinocyte, FaDu human hypopharynx squamous carcinoma, Dok human 
dysplastic oral keratinocyte) or after transfection in SAOS2 cells [54]. Also a direct 
interaction of TAp63α and ΔNp63α with Ubc9, which is essential for sumoylation, 
has been demonstrated in transiently transfected human embryonic retina 911 
cells [55]. It is possible to completely abolish the association among p63 and 
SUMO-1 by a K637E mutation, which also leads to a dramatically increase of the 
transcriptional activity of TAp63α on the RGC promoter. Furthermore, 
sumoylation is important for regulation of another p53-family member and 
regulates the intracellular concentration of p73 [56]. 
The results in this thesis together with previous findings show an interesting 
correlation between high transcriptional activity and low intracellular concentration 
[89]. There seem to be additional mechanisms regulating the intracellular 
concentration of transcriptionally active forms without affecting transcriptionally 
repressed forms of the protein. This hypothesis is supported by the finding that 
the intracellular concentration of TAp63α.FTL (barely detectable) is highly 
increased by an inactivation of this construct via an additional mutation in the 
DBD [Fig. 22]. This shows that even if the conformation is changed due to the 
mutation in the TID the protein seems to be stable if not transcriptionally active. It 
might be that the degradation of p63 only takes place if a transcriptionally active 
complex is formed on the DNA, which is regulated via ubiquitination by Itch, 
MDM2 or other E3-ligases that interact with p63 [93-99]. A difference between 
transcriptionally active and inactive forms has been observed i.e. for the estrogen 
receptor hERα as well [100]. 
All shown results were obtained using a reporter vector containing the p21 
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promoter or if the functionality is more general all transactivation experiment were 
carried out again using a promoter construct containing the bax promoter instead 
of the p21 promoter [Fig. 23]. The results for the constructs with mutations in the 
TID with an intact sumoylation site show the same pattern as in the case for the 
p21 promoter, suggesting that these identified amino acids are essential for 
keeping the protein in its inhibited form not only on the p21 promoter. 
For the wild type of TAp63α a mutation of the sumoylation site has the same 
effect on the bax promoter as on the p21 promoter. But for most of the other 
constructs an additional mutation which affects the sumoylation site seems to 
have no additional effect in terms of an additionally increased transcriptional 
activity. This could mean that some regulation mechanisms depend on the 
controlled promoter. While a mutation of the important amino acids (FTL) again 
leads to an activation of the protein and a single mutation of the sumoylation site 
has an effect on intracellular protein concentration the two effects are not able to 
become additive in a double mutation. 
To investigate the intracellular concentrations for the experiments on the bax 
promoter western blots of TAp63α.wt, TAp63α.K, TAp63α.FTL, TAp63α.FTL.K 
and TAp63γ.wt were carried out [Fig. 24]. The data shows that in case of the wild 
type and a single mutation in the sumoylation site the normalized transcriptional 
activity and therefore the result on the bax promoter is comparable to the result 
on the p21 promoter in this case. The concentrations of TAp63α.FTL with and 
without an additional mutation of the sumoylation are similar to each other and 
consequently also the normalized activities are similar. As a consequence the 
normalized transcriptional activity of these constructs is comparable to the data 
on the p21 promoter. 
The obvious difference on the bax promoter and the p21 promoter is, that there is 
no accumulation effect on the transcriptional activity due to the additional 
mutation in the sumoylation site for most constructs. Maybe sumoylation is 
dependent on the conformation of the protein and this can be different on various 
promoters. 
The transcriptional activity of a protein can also be influenced by its localization 
within the cell. For p73 localization signals seem to be important for its regulation 
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result of a different subcellular localization, therefore immunofluorescence has 
been carried out [Fig. 25]. The results clearly show all analyzed construct show 
exclusive nuclear localization. Accordingly the altered activities are not the result 
of differences in cellular localisation. 
The data about the identified active region (FTL) leads to the hypothesis that the 
increased activity of some constructs is due to a break up of important domain-
domain interactions. There is a region present in p63, called the QP-domain, that 
is of unclear relevance for structure and function of the protein. To test the 
hypothesis that this domain is not involved in the domain-domain interactions 
suggested between the identified amino acids (FTL) and other domains analogue 
experiments to those before have been carried out. In these experiments the 
used constructs lack the QP-domain and transcriptional activity was measured 
[Fig. 26]. The resulting data is very similar to the data of the experiments with the 
full length TAp63α and supports the idea that the QP-domain is not essential for 
this aspect of regulation of p63. 
To summarize, the transcriptional activity of TAp63α seems to be regulated in two 
different ways, one of them based an intrinsic mechanism (FTL) and one based 
on sumoylation.  There is a stretch of amino acids present in the TID, that seems 
to be important for this intrinsic activation mechanism. Transcriptionally inactive 
contracts show a higher intracellular concentration than active ones. The intrinsic 
mechanism seems to be similar on the investigated two promoters while 
sumoylation seems to be promoter dependent. For these two distinct control 
mechanisms the QP-domain seems not to be essential. To test if the identified 
amino acids, which have an impact on transcriptional activity, also have 
implications for the other α-isoform of p63, experiments with analogue mutations 
were carried out on ΔNp63α.  
 
 
7.2 Implications on ΔNp63α 
 
The dominant negative function of ΔNp63α towards TAp63α and therefore the 
function of the C-terminus in ΔNp63α is unclear. To test if the analogue 
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effect on inhibitory abilities of ΔNp63α or have other effects the most significant 
mutation (FTL) was applied to ΔNp63α. First of all the consequence on the 
transcriptional activity of ΔNp63α on the p21 promoter was tested by a 
transactivation assay [Fig. 27]. ΔNp63α does not get transcriptionally active on 
the p21 promoter due to this mutation. The protein has the same transcriptional 
activity as the wild type in this experiment. Due to the fact that ΔNp63α binds to 
enhancer elements of certain genes and promotes transcription in this way [102] 
it might be possible that the enhancing ability is altered by the mutation of FTL, 
but this has to be elucidated in further experiments. 
To investigate the implications on the inhibitory potential towards TAp63γ 
cotransfections with increasing amounts of DNA encoding ΔNp63α were carried 
out and overall transcriptional activity was measured [Fig. 28]. The difference 
between the inhibitory potential of ΔNp63α.wt and ΔNp63α.FTL is not that 
significant. Both proteins nearly inhibit all transcriptional activity with increasing 
amounts of transfected DNA and, according to the western blots, also increasing 
protein concentration of ΔNp63α. But it is important to remind that ΔNp63α can 
inhibit transcriptional activity in two different ways, either by directly interacting via 
the TID or indirectly by blocking the promoter. To distinguish between these 
effects an additional mutation in the DNA binding domain was added to 
ΔNp63α.FTL and net transcriptional activity was compared to ΔNp63α.DBD in 
titration experiments with TAp63γ. The two constructs carrying a mutation in the 
DBD are not capable of inhibiting TAp63γ indirectly by promoter binding. 
Like in the case of ΔNp63α and ΔNp63α.DBD the main part of the inhibition does 
not take place due to promoter binding, but seems to be because of direct 
inhibition mechanisms. A comparison between ΔNp63α.DBD and 
ΔNp63α.FTL.DBD shows that the inhibitory potential of ΔNp63α.FTL.DBD and 
most obviously as well as that of ΔNp63α.FTL by direct inhibition is greatly 
affected by the mutation in the TID. To rule out concentration effects the protein 
concentrations have been determined and activities have been normalized [Fig. 
29]. 
The western blots show that the double amount of transfected DNA of all ΔNp63α 
  81constructs lead to doubled intracellular protein concentrations. The curves for the 
normalized net transcriptional activities are similar to the curves for the relative 
net transcriptional activities. For ΔNp63α.FTL there seem to be two opposed 
effects. The indirect inhibition by DNA binding seems to be increased in this 
construct. With respective to the data obtained for TAp63α this result is not 
surprising. Maybe the mutation of FTL leads to an increased DNA-affinity in both 
isoforms. On the other hand direct inhibition via the TID seems to be abolished in 
the case of  ΔNp63α.FTL, also according to the data for TAp63α. This clearly 
shows the significance of the identified amino acids for both α-isoforms. 
At the C-terminus of both isoforms the identified amino acids influence the 
function of the proteins. The mutation of these amino acids maybe interrupts 
interactions within the protein and leads to an opening of the closed structure in 
both isoforms. The role of this regulation mechanism for ΔNp63α is not that 
obvious as in the case of TAp63α. But the consequence of ΔNp63α 
overexpression on certain genes important for osteoblastic differentiation [103] is 
demonstrated by RT-PCR [Fig. 30]. At least one promoter, most likely of the VDR, 
seems to be controlled by ΔNp63α. The decreased mRNA-level of the other 
genes might be a sequential effect due to the decreased intracellular level of 
VDR. It is unclear if the shown result might also be a result of a direct interaction 
of  ΔNp63α with another protein. But it is important to mention that in the 
introduced case there is a massive overexpression of ΔNp63α. In the natural 
case there might be a mechanism to achieve the same goal without the need of 
such a massive overexpression by increasing the DNA binding affinity of ΔNp63α. 
For a complete silencing (or enhancing) of the target genes with lower protein 
concentrations this would be essential. In this case the identified possible control 
mechanism would be of biological relevance, as an “active” form of ΔNp63α 
would have a higher affinity for DNA. This would be a way to regulate ΔNp63α 
without the need of any additional isoforms. 
As mentioned before ΔNp63α plays a crucial role in epithelial development. 
Maybe ΔNp63α is kept active in these tissues by the same kinase which activates 
TAp63α in Oocytes. Further experiments could proof this hypothesis i.e. if 
ΔNp63α also gets phosphorylated at the identified amino acids. The suggested 
  82way of regulating ΔNp63α in a similar manner than TAp63α but with different 
effects could be a way how epithelial development in terms of stem cell survival 
or differentiation is regulated. 
 
 
7.3 Analysis of TAp63γ 
 
The previous experiments about the inhibitory potential of ΔNp63α.FTL.DBD also 
showed that the maximal inhibition is around 50 % of the starting value. This 
could mean that at these concentration levels of ΔNp63α.FTL.DBD and 
TAp63γ.wt mainly homo- tetrameres of ΔNp63α.FTL.DBD with no transcriptional 
activity or hetero- tetrameres of the two different isoforms exist. A hetero-
tetramere of TAp63γ and  ΔNp63α.FTL.DBD  theoretically would behave like a 
dimer of TAp63γ due to only two functional DBD and TA domains. It is important 
to mention that the ΔNp63-construct is only able to inhibit via oligomerization with 
TAp63γ and neither by TA-TI interaction or promoter blocking. To investigate how 
a dimer of TAp63γ behaves in a transactivation assay an experiment was done 
with such a construct [Fig. 31]. After normalization the Dimer construct of TAp63γ 
(TAp63γ.D) has around 50 % transcriptional activity of the wild type. The same 
value as achieved in the titration experiment with TAp63γ.wt and 
ΔNp63α.FTL.DBD. It seems like a tetramere is required for high transcriptional 
activity of TAp63γ, a point that might also be important for TAp63α as already 
speculated before. To proof that the mutations in the tetrameric interface (M374Q, 
I378R) of the oligomerization domain really affect tetramerization, a shortened 
construct, which can be bacterially expressed, containing the oligomerization and 
the SAM domain with a deleted QP domain was used and analyzed via 
gelfiltration [Fig. 32]. In contrast to the wild type the construct containing the two 
mutations in the OD elutes at a higher volume and the elution volume 
corresponds to the molecular mass of a dimer. It is therefore assumed that the 
same mutation in TAp63γ leads to an inability in forming functional tetrameres. 
The cell culture data on TAp63γ.D shows a clear impact on the transcriptional 
activity, which seems to be due to the oligomeric state of the protein. 
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impact on transcriptional activity of the protein (similar to TAp63α) a deletion 
analysis was carried out and transcriptional activity was measured for these 
constructs [Fig. 33]. It is markable that the transcriptional activity does not change 
until a certain number of amino acids of the C-terminus are deleted. After this 
point the transcriptional activity is affected dramatically, but recovers after 
deletion of a number of additional amino acids. Those are the only deletions 
which show a significant effect on the relative transcriptional activity. 
To further elucidate this, two amino acids within the region which led to a drop in 
transcriptional activity after deletion were mutated to alanine, T426 and S428. 
The mutations had the same effect on the transcriptional activity like the deletion 
of this region [Fig. 34]. This might mean that post-translational changes are taking 
place at these amino acids which are necessary for the function of the protein. 
Maybe these residues are interacting with other nearby residues in this region if 
they are post-translationally modified, which also means that they can be 
regulated i.e. by phosphorylation. A deletion of additional amino acids might result 
in an activation because the interaction partners which have acted inhibitional and 
are bound by the phosphorylated threonine and serine in the active conformation 
of TAp63γ are lost. But this is also speculative and further data has to be obtained 
on that point. The phosphorylation prediction shows that at least one of the two 
identified amino acids gets phosphorylated [Fig. 35]. Nevertheless is it necessary 
to proof this like in the case of the other isoforms by additional experiments. 
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